https://www.wockhardt.com/investor/newspaper-publication-of-results-12/ 2022-10-18T07:43:07+00:00 https://www.wockhardt.com/investor/intimation-of-capital-raising-committee-meeting/ 2022-10-18T07:44:46+00:00 https://www.wockhardt.com/investor/outcome-of-capital-raising-committee-meeting/ 2022-10-18T07:45:19+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-10/ 2022-10-18T07:45:44+00:00 https://www.wockhardt.com/investor/redemption-of-preference-shares-2/ 2022-10-18T07:46:06+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulations/ 2022-10-18T09:12:36+00:00 https://www.wockhardt.com/investor/rating-update/ 2022-10-18T09:13:46+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-30th-september-2018/ 2022-10-18T09:14:21+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-2-3/ 2022-10-18T09:14:47+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-12/ 2022-10-18T09:15:03+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-40-of-sebi-lodr-regulation2015/ 2022-10-18T09:15:45+00:00 https://www.wockhardt.com/investor/regulation-73-certification-5/ 2022-10-18T09:16:06+00:00 https://www.wockhardt.com/investor/minutes-agm-2018/ 2022-10-18T11:16:27+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulations-2/ 2022-10-18T11:16:45+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-13/ 2022-10-18T11:17:07+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulations-3/ 2022-10-18T11:18:08+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-14/ 2022-10-18T11:18:57+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-15/ 2022-10-18T11:19:21+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-3/ 2022-10-18T11:19:45+00:00 https://www.wockhardt.com/investor/update-mandatory-dematerialization/ 2022-10-18T11:20:08+00:00 https://www.wockhardt.com/investor/reply-to-clarification-sought/ 2022-10-18T11:25:01+00:00 https://www.wockhardt.com/investor/submission-of-annual-report/ 2022-10-18T11:25:24+00:00 https://www.wockhardt.com/investor/proceedings-of-annual-general-meeting-2018/ 2022-10-18T11:26:13+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-04-08-2018/ 2022-10-18T11:26:35+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-2/ 2022-10-18T11:26:58+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-16/ 2022-10-18T11:27:44+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulations-4/ 2022-10-18T11:28:05+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulations-5/ 2022-10-18T11:28:24+00:00 https://www.wockhardt.com/investor/agm-and-book-closure-newspaper-publication-2/ 2022-10-18T11:37:40+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter1/ 2022-10-18T11:38:49+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-1-2/ 2022-10-18T11:39:18+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-june-2018-2/ 2022-10-18T11:40:25+00:00 https://www.wockhardt.com/investor/press-release-5/ 2022-10-18T11:41:06+00:00 https://www.wockhardt.com/investor/credit-rating-update/ 2022-10-18T11:48:22+00:00 https://www.wockhardt.com/investor/disclosure-under-prohibition-of-insider-trading-regulation/ 2022-10-18T11:48:43+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-16/ 2022-10-18T11:49:08+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-17/ 2022-10-18T11:49:55+00:00 https://www.wockhardt.com/investor/allotment-of-securities/ 2022-10-18T11:50:30+00:00 https://www.wockhardt.com/investor/disclosure-under-prohibition-of-insider-trading-regulation-2/ 2022-10-18T11:50:50+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-18/ 2022-10-18T11:51:09+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-4/ 2022-10-18T11:51:31+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-3/ 2022-10-18T11:54:38+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-04-05-2018/ 2022-10-18T11:55:15+00:00 https://www.wockhardt.com/investor/board-meeting-fund-raising/ 2022-10-18T11:55:51+00:00 https://www.wockhardt.com/investor/news-clarification-bse/ 2022-10-18T11:56:29+00:00 https://www.wockhardt.com/investor/news-clarification-nse/ 2022-10-18T11:57:07+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-13/ 2022-10-18T11:57:35+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-19/ 2022-10-18T11:58:05+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2018/ 2022-10-18T11:59:12+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-4-3/ 2022-10-18T12:00:02+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-4/ 2022-10-18T12:04:33+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-march-2018-2/ 2022-10-18T12:05:26+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-5/ 2022-10-18T12:06:00+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-40-of-sebi-lodr-regulations-2015-7/ 2022-10-18T12:06:29+00:00 https://www.wockhardt.com/investor/credit-rating-update-2/ 2022-10-18T12:36:27+00:00 https://www.wockhardt.com/investor/nse-update/ 2022-10-18T12:37:06+00:00 https://www.wockhardt.com/investor/bse-update/ 2022-10-18T12:37:41+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report-4/ 2022-10-21T04:55:05+00:00 https://www.wockhardt.com/investor/nse-update-2/ 2022-10-21T04:55:38+00:00 https://www.wockhardt.com/investor/bse-update-2/ 2022-10-21T04:56:09+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-11/ 2022-10-21T04:56:44+00:00 https://www.wockhardt.com/investor/bse-update-3/ 2022-10-21T04:57:31+00:00 https://www.wockhardt.com/investor/nse-update-3/ 2022-10-21T04:57:59+00:00 https://www.wockhardt.com/investor/allotment-of-securities-2/ 2022-10-21T04:58:39+00:00 https://www.wockhardt.com/investor/postal-ballot-newspaper-publication-4/ 2022-10-21T05:03:48+00:00 https://www.wockhardt.com/investor/rating-update-2/ 2022-10-21T05:04:29+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-4/ 2022-10-21T05:06:47+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-20/ 2022-10-21T05:07:24+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-29-01-2018/ 2022-10-21T05:38:10+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-14/ 2022-10-21T05:40:00+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-3-3/ 2022-10-21T05:40:29+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-december-2017-2/ 2022-10-21T05:40:59+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-december-2017/ 2022-10-21T05:42:00+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-3/ 2022-10-21T05:42:30+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-22/ 2022-10-21T05:43:08+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-12/ 2022-10-21T06:00:37+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-18/ 2022-10-21T06:09:02+00:00 https://www.wockhardt.com/investor/allotment-disclosure/ 2022-10-21T06:12:27+00:00 https://www.wockhardt.com/investor/allotment-of-securities-3/ 2022-10-21T06:13:23+00:00 https://www.wockhardt.com/investor/trading-disclosure/ 2022-10-21T06:14:16+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-23/ 2022-10-21T06:15:29+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-24/ 2022-10-21T06:16:08+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-2/ 2022-10-21T06:16:56+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-25/ 2022-10-21T06:17:35+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-19/ 2022-10-21T06:20:58+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-26/ 2022-10-21T06:21:35+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-2-4/ 2022-10-21T06:22:08+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-2/ 2022-10-21T06:22:42+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-20/ 2022-10-21T06:23:15+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-15/ 2022-10-21T06:23:52+00:00 https://www.wockhardt.com/investor/regulation-73-confirmation/ 2022-10-21T06:24:21+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-13/ 2022-10-21T06:24:53+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-21/ 2022-10-21T06:25:35+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-27/ 2022-10-21T06:26:44+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-22/ 2022-10-21T06:27:54+00:00 https://www.wockhardt.com/investor/press-release-6/ 2022-10-21T06:29:01+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-28/ 2022-10-21T06:31:07+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-june-2017-2/ 2022-10-21T06:31:42+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-16/ 2022-10-21T06:33:09+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-1-3/ 2022-10-21T06:33:48+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-1-2/ 2022-10-21T06:35:06+00:00 https://www.wockhardt.com/investor/notice-of-agm-and-book-closure/ 2022-10-21T06:35:49+00:00 https://www.wockhardt.com/investor/rating-update-3/ 2022-10-21T06:36:24+00:00 https://www.wockhardt.com/investor/press-release-7/ 2022-10-21T06:37:02+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-23/ 2022-10-21T06:37:35+00:00 https://www.wockhardt.com/investor/press-release-8/ 2022-10-21T06:40:01+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-24/ 2022-10-21T06:40:36+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-6/ 2022-10-21T06:41:47+00:00 https://www.wockhardt.com/investor/allotment-of-securities-4/ 2022-10-21T06:42:53+00:00 https://www.wockhardt.com/investor/intimation-of-update/ 2022-10-21T06:43:28+00:00 https://www.wockhardt.com/investor/disclosure/ 2022-10-21T06:44:31+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-3/ 2022-10-21T06:45:47+00:00 https://www.wockhardt.com/investor/update-on-issuance-of-duplicate-share-certificate/ 2022-10-21T06:47:08+00:00 https://www.wockhardt.com/investor/intimation-of-board-meeting-4th-may-2017/ 2022-10-21T06:50:46+00:00 https://www.wockhardt.com/investor/intimation-of-board-meeting-4th-may-2017-2/ 2022-10-21T06:51:20+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-march-2017-2/ 2022-10-21T06:52:12+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-march-2017/ 2022-10-21T06:52:48+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-4-2/ 2022-10-21T06:53:26+00:00 https://www.wockhardt.com/investor/regulation-73-confirmation-2/ 2022-10-21T06:54:06+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-40-of-sebi-lodr-regulations-2015-8/ 2022-10-21T06:54:43+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-4-4/ 2022-10-21T06:55:15+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-15/ 2022-10-21T06:55:48+00:00 https://www.wockhardt.com/investor/press-release-9/ 2022-10-21T06:56:23+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-16/ 2022-10-21T06:57:42+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-17/ 2022-10-21T06:58:16+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-18/ 2022-10-21T06:58:55+00:00 https://www.wockhardt.com/investor/update-3/ 2022-10-21T06:59:25+00:00 https://www.wockhardt.com/investor/intimation-of-update-2/ 2022-10-21T07:00:02+00:00 https://www.wockhardt.com/investor/intimation-of-update-3/ 2022-10-21T07:00:35+00:00 https://www.wockhardt.com/investor/intimation-of-update-4/ 2022-10-21T07:01:15+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-4/ 2022-10-21T07:01:53+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-7/ 2022-10-21T07:03:02+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report-6/ 2022-10-21T07:04:41+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-3-4/ 2022-10-21T07:05:15+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-3-2/ 2022-10-21T07:06:24+00:00 https://www.wockhardt.com/investor/update-4/ 2022-10-21T07:07:04+00:00 https://www.wockhardt.com/investor/update-bse/ 2022-10-21T07:07:40+00:00 https://www.wockhardt.com/investor/update-nse/ 2022-10-21T07:08:11+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-31st-december-2016/ 2022-10-21T07:10:19+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-december-2016/ 2022-10-21T07:10:39+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-19/ 2022-10-21T07:11:20+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-20/ 2022-10-21T07:11:49+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-21/ 2022-10-21T07:12:17+00:00 https://www.wockhardt.com/investor/update-5/ 2022-10-21T07:12:55+00:00 https://www.wockhardt.com/investor/update-6/ 2022-10-21T07:13:54+00:00 https://www.wockhardt.com/investor/rating-update-4/ 2022-10-21T07:14:32+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-6/ 2022-10-21T07:15:08+00:00 https://www.wockhardt.com/investor/update-7/ 2022-10-21T07:16:46+00:00 https://www.wockhardt.com/investor/board-meeting-updates-2/ 2022-10-21T07:18:27+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-30th-september-2016/ 2022-10-21T07:19:35+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint-quarter-2-2/ 2022-10-21T07:24:06+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-22/ 2022-10-21T07:52:11+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-2-5/ 2022-10-21T07:53:25+00:00 https://www.wockhardt.com/investor/regulation-73-confirmation-3/ 2022-10-21T07:54:00+00:00 https://www.wockhardt.com/investor/update-8/ 2022-10-21T07:54:32+00:00 https://www.wockhardt.com/investor/update-9/ 2022-10-21T07:55:03+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-23/ 2022-10-21T07:55:52+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-24/ 2022-10-21T07:56:54+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-25/ 2022-10-21T07:57:34+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-26/ 2022-10-21T07:58:58+00:00 https://www.wockhardt.com/investor/17th-agm-minutes/ 2022-10-21T07:59:41+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-27/ 2022-10-21T08:00:14+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-25/ 2022-10-21T08:00:55+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-6/ 2022-10-21T08:01:44+00:00 https://www.wockhardt.com/investor/proceedings-of-17th-agm/ 2022-10-21T08:02:15+00:00 https://www.wockhardt.com/investor/17th-agm-voting-results/ 2022-10-21T08:02:45+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-28/ 2022-10-21T08:03:24+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-29/ 2022-10-21T08:04:03+00:00 https://www.wockhardt.com/investor/allotment-2/ 2022-10-21T08:05:06+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-17/ 2022-10-21T09:07:38+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-30/ 2022-10-21T09:08:39+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-june-2016/ 2022-10-21T09:10:56+00:00 https://www.wockhardt.com/investor/news-clarification-5/ 2022-10-21T09:11:31+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-30/ 2022-10-21T09:12:17+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-report/ 2022-10-21T09:13:57+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaints-quarter-1/ 2022-10-21T09:14:54+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-1-4/ 2022-10-21T09:16:10+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-31/ 2022-10-21T09:22:12+00:00 https://www.wockhardt.com/investor/duplicate-share-certificate-request/ 2022-10-21T09:22:56+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-32/ 2022-10-21T09:23:35+00:00 https://www.wockhardt.com/investor/update-10/ 2022-10-21T09:24:10+00:00 https://www.wockhardt.com/investor/duplicate-share-certificate-request-2/ 2022-10-21T09:26:18+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-7/ 2022-10-21T09:26:55+00:00 https://www.wockhardt.com/investor/outcome-of-esos-compensation-committee-meeting/ 2022-10-21T09:27:44+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-32/ 2022-10-21T09:28:21+00:00 https://www.wockhardt.com/investor/board-meeting-notice/ 2022-10-21T09:29:00+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-4th-quarter/ 2022-10-21T09:34:29+00:00 https://www.wockhardt.com/investor/duplicate-share-certificate-request-3/ 2022-10-21T09:36:22+00:00 https://www.wockhardt.com/investor/regulation73-confirmation/ 2022-10-21T09:37:27+00:00 https://www.wockhardt.com/investor/takeover-code-annual-disclosure/ 2022-10-21T09:38:03+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-33/ 2022-10-21T09:38:47+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-33/ 2022-10-21T09:39:36+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-34/ 2022-10-21T09:43:02+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-35/ 2022-10-21T09:44:12+00:00 https://www.wockhardt.com/investor/update-11/ 2022-10-21T09:46:51+00:00 https://www.wockhardt.com/investor/sebi-takeover-code-disclosure/ 2022-10-21T09:49:48+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-preference-shares/ 2022-10-21T09:50:25+00:00 https://www.wockhardt.com/investor/rating-update-5/ 2022-10-21T09:52:20+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-36/ 2022-10-21T09:53:00+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-37/ 2022-10-21T09:53:42+00:00 https://www.wockhardt.com/investor/board-meeting-notice-2/ 2022-10-21T09:57:09+00:00 https://www.wockhardt.com/investor/credit-rating-updates/ 2022-10-21T10:00:12+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-report-2/ 2022-10-21T10:00:49+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-38/ 2022-10-21T10:01:26+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-39/ 2022-10-21T10:02:55+00:00 https://www.wockhardt.com/investor/news-clarification-bse-2/ 2022-10-21T10:04:12+00:00 https://www.wockhardt.com/investor/updates-2/ 2022-10-21T10:04:52+00:00 https://www.wockhardt.com/investor/corporate-governance-report-3rd-quarter/ 2022-10-21T10:05:27+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-40/ 2022-10-21T10:06:01+00:00 https://www.wockhardt.com/investor/reg-305-dis-08012016/ 2022-10-21T10:06:34+00:00 https://www.wockhardt.com/investor/press-release-wck-5222/ 2022-10-27T12:34:57+00:00 https://www.wockhardt.com/investor/update-cp-rating/ 2022-10-27T12:51:39+00:00 https://www.wockhardt.com/investor/update-unrestricted-gmp-certificate-by-uk-mhr/ 2022-10-28T06:34:42+00:00 https://www.wockhardt.com/investor/appointment-of-mr-pramod-gupta-as-the-chief-financial-officer-of-the-company/ 2022-10-28T09:51:28+00:00 https://www.wockhardt.com/investor/new-spaper-publication-rights-issue-22-03-2022/ 2022-10-28T09:54:46+00:00 https://www.wockhardt.com/investor/postal-ballot-newspaper-publication-5/ 2022-10-28T10:02:20+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-7/ 2022-10-28T10:25:05+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-8/ 2022-10-28T10:40:02+00:00 https://www.wockhardt.com/investor/board-meeting-notice-10th-november-2016/ 2022-10-28T11:34:53+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarier-ended-30th-september-2016/ 2022-10-28T11:48:17+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-40-of-sebi-lodr-regulations-2015-9/ 2022-10-28T12:02:22+00:00 https://www.wockhardt.com/investor/extract-of-results-nev-spaper-publication/ 2022-10-28T12:06:35+00:00 https://www.wockhardt.com/investor/issuance-of-dupucate-shares-certificate/ 2022-10-28T12:23:04+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-shares-certiicate/ 2022-10-28T12:56:04+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-41/ 2022-10-28T13:12:38+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-29/ 2022-10-29T17:44:24+00:00 https://www.wockhardt.com/investor/clarification/ 2022-10-29T18:20:13+00:00 https://www.wockhardt.com/investor/related-pariy-transaction-report-for-the-half-year-ended-31st-september-2021/ 2022-10-30T17:01:02+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-31/ 2022-10-31T05:50:38+00:00 https://www.wockhardt.com/investor/agm-and-book-closure-3/ 2022-10-31T06:02:10+00:00 https://www.wockhardt.com/investor/certifcate-under-regulation-40-of-sebi-lodr-regulations-2015/ 2022-10-31T06:14:13+00:00 https://www.wockhardt.com/investor/corporate-governance-4th-quarter-14-april-2016/ 2022-10-31T06:17:47+00:00 https://www.wockhardt.com/investor/statement-of-investor-compliant/ 2022-10-31T06:25:15+00:00 https://www.wockhardt.com/investor/q3-fy-2015-16-results-and-pr/ 2022-10-31T06:39:53+00:00 https://www.wockhardt.com/investor/q3-fy-2015-16-lr-and-results/ 2022-10-31T06:41:46+00:00 https://www.wockhardt.com/investor/bm-nev-spaper-advertisement/ 2022-10-31T06:48:29+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaint/ 2022-10-31T06:52:57+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-quarter-ended-31st-december-2015/ 2022-10-31T07:27:57+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-quarter-ended-31st-march-2016/ 2022-10-31T07:28:49+00:00 https://www.wockhardt.com/investor/nev-s-clarification-nse/ 2022-10-31T07:31:23+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-september-2017-2/ 2022-10-31T08:10:32+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-for-the-quarter-ended-30th-september-201/ 2022-10-31T08:11:24+00:00 https://www.wockhardt.com/investor/clarification-to-the-stock-exchanges/ 2022-10-31T12:57:35+00:00 https://www.wockhardt.com/investor/minutes-agm-2017/ 2022-10-31T16:10:14+00:00 https://www.wockhardt.com/investor/insider-trading-disclosure-14/ 2022-10-31T16:17:21+00:00 https://www.wockhardt.com/investor/agm-notice-nevwspaper-publication/ 2022-10-31T18:05:46+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-27-05-2021/ 2022-10-31T20:04:56+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-18/ 2022-10-31T20:08:21+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-19/ 2022-10-31T20:10:20+00:00 https://www.wockhardt.com/investor/transfer-of-shares-to-iepf-newspaper-publication-2/ 2022-10-31T20:11:37+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-2-8-2017/ 2022-11-01T05:04:31+00:00 https://www.wockhardt.com/investor/proceedings-of-annual-general-meetings/ 2022-11-01T05:08:41+00:00 https://www.wockhardt.com/investor/annual-general-meeting-voting-results-and-scrutinizers-report/ 2022-11-01T05:11:45+00:00 https://www.wockhardt.com/investor/agm-and-book-closure-nevwspaper-publication/ 2022-11-01T05:17:52+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report-5/ 2022-11-01T05:27:35+00:00 https://www.wockhardt.com/investor/postal-ballot-nev-spaper-publication/ 2022-11-01T05:34:43+00:00 https://www.wockhardt.com/investor/postal-ballot-updates-5/ 2022-11-01T05:38:10+00:00 https://www.wockhardt.com/investor/extract-of-results-newspaper-publication/ 2022-11-01T05:43:46+00:00 https://www.wockhardt.com/investor/extract-of-results-newspaper-publication-2/ 2022-11-01T06:12:59+00:00 https://www.wockhardt.com/investor/intimation-of-board-meeting/ 2022-11-01T06:20:01+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-5/ 2022-11-01T06:25:46+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report/ 2022-11-01T06:38:19+00:00 https://www.wockhardt.com/investor/postal-ballot-newispaper-publication/ 2022-11-01T06:40:18+00:00 https://www.wockhardt.com/investor/postal-ballot-updates/ 2022-11-01T06:43:38+00:00 https://www.wockhardt.com/investor/credii-raiing-updaie-of-care/ 2022-11-01T06:50:51+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-september-2018-2/ 2022-11-01T06:59:24+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaints-quarter-2-2/ 2022-11-01T07:02:50+00:00 https://www.wockhardt.com/investor/allotiment-of-34750-equity-shares-under-esos-scheme/ 2022-11-01T07:05:58+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report-2/ 2022-11-01T07:20:20+00:00 https://www.wockhardt.com/investor/postal-ballot-newspaper-publication-2/ 2022-11-01T07:29:18+00:00 https://www.wockhardt.com/investor/annual-general-meeting-voting-result-and-scrutinizers-report/ 2022-11-01T07:35:11+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certifcate/ 2022-11-01T07:41:42+00:00 https://www.wockhardt.com/investor/intimation-of-notice-of-board-meeting-4th-august-2018/ 2022-11-01T07:44:56+00:00 https://www.wockhardt.com/investor/reconcilation-of-share-capital-audit-report-for-the-quarter-ended-30th-june-2018/ 2022-11-01T07:46:51+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-26/ 2022-11-01T07:58:48+00:00 https://www.wockhardt.com/investor/agm-and-book-closure-2/ 2022-11-01T08:04:48+00:00 https://www.wockhardt.com/investor/postal-ballot-voting-results-and-scrutinizers-report-3/ 2022-11-01T09:23:30+00:00 https://www.wockhardt.com/investor/postal-ballot-newspaper-publication-3/ 2022-11-01T09:26:06+00:00 https://www.wockhardt.com/investor/takeover-code-disclosure-under-reg-101-10-2/ 2022-11-01T09:44:32+00:00 https://www.wockhardt.com/investor/regulation-713-certification/ 2022-11-01T09:46:33+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-34/ 2022-11-01T10:07:06+00:00 https://www.wockhardt.com/investor/issuance-of-duplicate-share-certificate-21/ 2022-11-01T10:13:42+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-37/ 2022-11-01T10:22:58+00:00 https://www.wockhardt.com/investor/related-party-transactions-disclosure-on-consolidated-basis-for-the-half-year-ended-30th-september-2019/ 2022-11-01T10:26:28+00:00 https://www.wockhardt.com/investor/outcome-of-board-meeting-07-11-2019-2/ 2022-11-01T10:35:04+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-40-of-sebi-lodr-regulations-2015-5/ 2022-11-01T10:44:13+00:00 https://www.wockhardt.com/investor/statement-of-investor-complaints-quarter-2/ 2022-11-01T10:46:13+00:00 https://www.wockhardt.com/investor/allotiment-of-equity-shares-esop-30000/ 2022-11-01T11:03:15+00:00 https://www.wockhardt.com/investor/reconcilation-of-share-capital-audit-report-quarter-1/ 2022-11-01T11:18:01+00:00 https://www.wockhardt.com/investor/submission-of-annual-report-fy-2018-19/ 2022-11-01T11:26:08+00:00 https://www.wockhardt.com/investor/new-spaper-notice-of-the-board-meeting/ 2022-11-01T11:36:35+00:00 https://www.wockhardt.com/investor/allotiment-of-equity-shares-esop-18800/ 2022-11-01T11:38:38+00:00 https://www.wockhardt.com/investor/related-party-transactions-disclosure-on-consolidated-basis-for-the-half-year-ending-31st-march-2019/ 2022-11-01T11:40:27+00:00 https://www.wockhardt.com/investor/secretarial-compliance-report-31st-march-2019/ 2022-11-01T11:43:05+00:00 https://www.wockhardt.com/investor/initial-disclosure-fund-raising-by-issuance-of-debt-securities-by-large-entities/ 2022-11-01T11:46:31+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-14/ 2022-11-01T11:56:30+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-15/ 2022-11-01T11:56:32+00:00 https://www.wockhardt.com/investor/se-code-of-fair-disclosure/ 2022-11-01T12:08:04+00:00 https://www.wockhardt.com/investor/issuance-of-duplcate-share-certiicate/ 2022-11-01T12:11:05+00:00 https://www.wockhardt.com/investor/regulation-7-3-certification/ 2022-11-01T12:11:34+00:00 https://www.wockhardt.com/investor/incorporation-of-indian-wholly-ovned-subsidiaries-of-wockhardt-limited/ 2022-11-01T12:16:40+00:00 https://www.wockhardt.com/investor/newspaper-publication-resulis/ 2022-11-01T12:27:54+00:00 https://www.wockhardt.com/investor/postal-ballot-minutes-2/ 2022-11-01T12:44:08+00:00 https://www.wockhardt.com/investor/related-pariy-transactions-disclosure-on-consolidated-basis-for-the-half-year-ended-30th-september-2020/ 2022-11-02T08:07:56+00:00 https://www.wockhardt.com/investor/outcome-of-the-capital-raising-comimittee-meeting-13-10-2020-2/ 2022-11-02T10:12:54+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-27/ 2022-11-02T10:22:31+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-26/ 2022-11-02T10:22:42+00:00 https://www.wockhardt.com/investor/transfer-of-shares-to-iepf-newspaper-publication-3/ 2022-11-02T11:09:03+00:00 https://www.wockhardt.com/investor/press-release-31-08-2020/ 2022-11-02T11:23:53+00:00 https://www.wockhardt.com/investor/newspaper-publication-of-results-7/ 2022-11-02T11:24:04+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-28/ 2022-11-02T11:39:20+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-26/ 2022-11-02T11:39:23+00:00 https://www.wockhardt.com/investor/transfer-of-shares-to-iepf-nev-spaper-publication/ 2022-11-02T11:49:47+00:00 https://www.wockhardt.com/investor/closure-of-trading-windov/ 2022-11-02T11:59:49+00:00 https://www.wockhardt.com/investor/closure-of-trading-windov-2/ 2022-11-02T11:59:57+00:00 https://www.wockhardt.com/investor/closure-of-trading-window-31-march-2020/ 2022-11-02T12:30:51+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulatio/ 2022-11-02T12:32:47+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-20-march-2020/ 2022-11-02T12:35:43+00:00 https://www.wockhardt.com/investor/takeover-code-disclosure-20-03-2020-20-march-2020/ 2022-11-02T12:36:46+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-16-march-2020/ 2022-11-02T12:46:38+00:00 https://www.wockhardt.com/investor/capital-raising-comimittee-meeting-notice-12-march-2020/ 2022-11-02T12:48:32+00:00 https://www.wockhardt.com/investor/rating-updates-india-rating-25-february-2020/ 2022-11-02T12:51:18+00:00 https://www.wockhardt.com/investor/reconciliation-of-share-capital-audit-report-quarter-3/ 2022-11-02T13:07:25+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-june-2020/ 2022-11-03T06:25:01+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-19/ 2022-11-04T12:25:55+00:00 https://www.wockhardt.com/investor/statement-of-investors-compliants-for-the-quarter-ended-31st-march-2021/ 2022-11-05T11:46:44+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-march-2022/ 2022-11-05T11:51:14+00:00 https://www.wockhardt.com/investor/news-clarification/ 2022-11-05T11:58:39+00:00 https://www.wockhardt.com/investor/news-clarification-2/ 2022-11-05T11:59:05+00:00 https://www.wockhardt.com/investor/allotment-of-non-convertible-debentures/ 2022-11-05T17:36:22+00:00 https://www.wockhardt.com/investor/rating-updates-care-rating/ 2022-11-05T17:40:03+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-5/ 2022-11-06T13:00:46+00:00 https://www.wockhardt.com/investor/outcome-of-the-credit-facilties-committee-meeting/ 2022-11-06T13:29:19+00:00 https://www.wockhardt.com/investor/allotment-of-non-convertible-debentures-3/ 2022-11-06T13:38:26+00:00 https://www.wockhardt.com/investor/allotment-of-non-convertible-debentures-4/ 2022-11-06T13:38:32+00:00 https://www.wockhardt.com/investor/rating-updates-care-ratings-ncd/ 2022-11-06T14:05:39+00:00 https://www.wockhardt.com/investor/rating-updates-india-ratings/ 2022-11-06T15:53:55+00:00 https://www.wockhardt.com/investor/agm-notice-and-record-date-newspaper-publication/ 2022-11-06T16:35:20+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-48/ 2022-11-07T06:00:28+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-47/ 2022-11-07T06:06:32+00:00 https://www.wockhardt.com/investor/annual-report-2021-2022/ 2023-01-05T11:37:49+00:00 https://www.wockhardt.com/investor/annual-report-2007/ 2023-02-27T06:33:12+00:00 https://www.wockhardt.com/investor/annual-report-2008/ 2023-02-27T06:34:02+00:00 https://www.wockhardt.com/investor/annual-report-2009-2010/ 2023-02-27T06:36:25+00:00 https://www.wockhardt.com/investor/wockhardt-consolidated-financial-highlights/ 2023-03-03T09:55:27+00:00 https://www.wockhardt.com/investor/code-of-practices-_-procedures-for-fair-disclosure-of-upsi/ 2023-03-04T09:09:24+00:00 https://www.wockhardt.com/investor/policy-for-determining-material-subsidiary/ 2023-03-04T09:42:16+00:00 https://www.wockhardt.com/investor/policy-on-materiality-of-and-dealing-with-related-party-transaction-2/ 2023-03-04T09:42:48+00:00 https://www.wockhardt.com/investor/familiarisation-programme-2020-21/ 2023-03-04T09:43:23+00:00 https://www.wockhardt.com/investor/csr-policy/ 2023-03-04T09:43:57+00:00 https://www.wockhardt.com/investor/policy-determining-materiality-of-events/ 2023-03-04T09:45:15+00:00 https://www.wockhardt.com/investor/dividend-distribution-policy/ 2023-03-04T09:45:32+00:00 https://www.wockhardt.com/investor/wl-remuneration-policy/ 2023-03-04T09:45:40+00:00 https://www.wockhardt.com/investor/archival-policy/ 2023-03-04T09:46:49+00:00 https://www.wockhardt.com/investor/draft-letter-of-appointment-of-independent-diector-including-terms-of-reference/ 2023-03-04T09:47:06+00:00 https://www.wockhardt.com/investor/familiarisation-programme/ 2023-03-04T09:47:24+00:00 https://www.wockhardt.com/investor/whistle-blower-policy/ 2023-03-04T09:47:41+00:00 https://www.wockhardt.com/investor/code-of-conduct/ 2023-03-04T09:49:13+00:00 https://www.wockhardt.com/investor/annual-secretarial-compliance-report-for-the-year-ended-march-31-2020/ 2023-03-05T14:36:46+00:00 https://www.wockhardt.com/investor/annual-secretarial-compliance-report-for-the-year-ended-march-31-2021/ 2023-03-05T14:37:11+00:00 https://www.wockhardt.com/investor/annual-secretarial-compliance-report-for-the-year-ended-march-31-2022/ 2023-03-05T14:37:25+00:00 https://www.wockhardt.com/investor/intimation-under-regulation-30-of-the-securities-and-exchange-board-of-india-listing-obligations-and-disclosure-requirements-regulations-2015-as-amended-sebi-listing-regulations/ 2023-03-05T14:49:34+00:00 https://www.wockhardt.com/investor/rights-issue-letter-of-offer/ 2023-03-05T14:49:54+00:00 https://www.wockhardt.com/investor/rights-issue-application-form/ 2023-03-05T14:50:13+00:00 https://www.wockhardt.com/investor/rights-issue-abridged-letter-of-offer/ 2023-03-05T14:50:36+00:00 https://www.wockhardt.com/investor/annual-secretarial-compliance-report-for-the-year-ended-march-31-2019/ 2023-03-05T14:56:04+00:00 https://www.wockhardt.com/investor/rights-issue-faqs/ 2023-03-05T14:57:10+00:00 https://www.wockhardt.com/investor/faqs-forms-day-day-requirement-shareholders-2/ 2023-03-05T15:08:31+00:00 https://www.wockhardt.com/investor/shares-transfer-to-iepf/ 2023-03-05T15:23:08+00:00 https://www.wockhardt.com/investor/shares-transfer-to-iepf-2nd-interim-dividend-2013-14/ 2023-03-05T15:24:49+00:00 https://www.wockhardt.com/investor/shares-transfer-to-iepf-interim-dividend-fy-2014-15/ 2023-03-05T15:25:08+00:00 https://www.wockhardt.com/investor/shares-transfer-to-iepf-final-dividend-2012-13/ 2023-03-05T15:28:34+00:00 https://www.wockhardt.com/investor/shares-transfer-to-iepf-interim-dividend-2013-14/ 2023-03-05T15:29:20+00:00 https://www.wockhardt.com/investor/dividend-2016-17-interim/ 2023-03-05T15:33:52+00:00 https://www.wockhardt.com/investor/for-the-quarter-ended-31st-march-2008/ 2023-03-05T16:18:03+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q2-jul-sep-2012-2/ 2023-03-05T16:22:44+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q3-oct-dec-2012-2/ 2023-03-05T16:24:36+00:00 https://www.wockhardt.com/investor/for-the-quarter-ended-31st-december-2010-a6538/ 2023-03-05T16:25:32+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q1-apr-jun-2013/ 2023-03-05T16:27:29+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q2-jul-sept-2013-2/ 2023-03-05T16:27:37+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q3-oct-dec-2013/ 2023-03-05T16:27:49+00:00 https://www.wockhardt.com/investor/wockhardt-annual-consolidated-financial-results-fy-13-14/ 2023-03-05T16:28:11+00:00 https://www.wockhardt.com/investor/financial-results-fy-2015-16-q3-oct-dec-15/ 2023-03-05T16:30:08+00:00 https://www.wockhardt.com/investor/annual-financial-results-fy-2016-17/ 2023-03-05T16:52:39+00:00 https://www.wockhardt.com/investor/q3-fy16-17-financial-results/ 2023-03-05T16:58:43+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q1/ 2023-03-05T17:34:43+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q2/ 2023-03-05T17:34:47+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q3/ 2023-03-05T17:34:52+00:00 https://www.wockhardt.com/investor/annual-financial-results-2019-20/ 2023-03-05T17:34:58+00:00 https://www.wockhardt.com/investor/financial-results-fy-2020-21-q1/ 2023-03-05T17:37:01+00:00 https://www.wockhardt.com/investor/financial-results-fy21-q2/ 2023-03-05T17:37:10+00:00 https://www.wockhardt.com/investor/financial-results-fy21-q3/ 2023-03-05T17:37:16+00:00 https://www.wockhardt.com/investor/financial-results-fy21-q4/ 2023-03-05T17:37:27+00:00 https://www.wockhardt.com/investor/financial-results-fy22-q1-2/ 2023-03-05T17:42:13+00:00 https://www.wockhardt.com/investor/financial-results-fy22-q3/ 2023-03-05T17:42:28+00:00 https://www.wockhardt.com/investor/financial-results-fy22-q4/ 2023-03-05T17:42:35+00:00 https://www.wockhardt.com/investor/for-the-quarter-ended-30th-september-2010/ 2023-03-05T17:44:06+00:00 https://www.wockhardt.com/investor/financial-results-fy-2018-19-q2-jul-sep-2018/ 2023-03-05T17:48:06+00:00 https://www.wockhardt.com/investor/financial-results-fy-2018-19-q1-april-june-2018-707a2/ 2023-03-05T17:48:17+00:00 https://www.wockhardt.com/investor/wockhardt-to-restructure-us-business-to-save-12-million-per-year-sees-debt-pare-down/ 2023-03-07T09:32:27+00:00 https://www.wockhardt.com/investor/agm-notice-and-record-date-newspaper-publication-2/ 2023-03-07T17:24:45+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-7/ 2023-03-07T17:28:04+00:00 https://www.wockhardt.com/investor/disclosure-under-insider-trading-regulation-34/ 2023-03-07T17:29:21+00:00 https://www.wockhardt.com/investor/disclosure-under-takeover-code-regulation-34/ 2023-03-07T17:29:25+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-13/ 2023-03-07T17:29:31+00:00 https://www.wockhardt.com/investor/report-on-corporate-governance-quarter-3/ 2023-03-07T17:29:36+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31st-december-2019-2/ 2023-03-07T17:29:38+00:00 https://www.wockhardt.com/investor/certificate-under-regulation-745-of-sebi-dp-regulations-2018/ 2023-03-07T17:29:44+00:00 https://www.wockhardt.com/investor/request-for-issuance-of-duplicate-share-certificate-17/ 2023-03-08T06:31:41+00:00 https://www.wockhardt.com/investor/partnership-with-uk-covid-19-vaccines-03-08-2020/ 2023-03-08T06:39:26+00:00 https://www.wockhardt.com/investor/appt-of-akhilesh-gupta-as-add-director-31-08-2020/ 2023-03-08T06:40:04+00:00 https://www.wockhardt.com/investor/uk-prime-minister-visit-01-12-2020/ 2023-03-08T06:41:30+00:00 https://www.wockhardt.com/investor/ext-of-covid-19-contrac-uk-gov-10-02-2021/ 2023-03-08T06:42:43+00:00 https://www.wockhardt.com/investor/visit-of-hrh-05-07-2021/ 2023-03-08T07:20:41+00:00 https://www.wockhardt.com/investor/appointment-of-cs-resignation-of-cfo-22-07-2021/ 2023-03-08T07:22:18+00:00 https://www.wockhardt.com/investor/vaccination-rollout-in-uk-27-07-2021/ 2023-03-08T07:23:22+00:00 https://www.wockhardt.com/investor/rdif-wockhardt-partnership-13-08-2021/ 2023-03-08T07:25:35+00:00 https://www.wockhardt.com/investor/partnership-with-jemincare-26-08-2021/ 2023-03-08T07:26:52+00:00 https://www.wockhardt.com/investor/wbl-acquisition-09-11-2021/ 2023-03-08T07:29:31+00:00 https://www.wockhardt.com/investor/appointment-of-cfo-27-01-2022/ 2023-03-08T07:31:02+00:00 https://www.wockhardt.com/investor/cdsco-approval-for-export-of-sputnik-08-02-2022/ 2023-03-08T07:41:16+00:00 https://www.wockhardt.com/investor/rights-issue-newspaper-intimation-se-13-03-2022/ 2023-03-08T07:55:05+00:00 https://www.wockhardt.com/investor/nih-usa-16-03-2022/ 2023-03-08T07:56:47+00:00 https://www.wockhardt.com/investor/sii-collaboration-se-20-03-2022/ 2023-03-08T07:57:47+00:00 https://www.wockhardt.com/investor/rights-issue-newspaper-intimation-se-22-03-2022/ 2023-03-08T07:59:41+00:00 https://www.wockhardt.com/investor/rights-issue-newspaper-intimation-se-31-03-2022/ 2023-03-08T08:01:59+00:00 https://www.wockhardt.com/investor/initiation-of-phase-3-trial-wck-5222-16-08-2022/ 2023-03-08T12:47:55+00:00 https://www.wockhardt.com/investor/withdrawal-of-nominee-directorship-03-08-2022/ 2023-03-08T12:50:21+00:00 https://www.wockhardt.com/investor/resignation-of-pramod-gupta-07-06-2022/ 2023-03-08T12:51:43+00:00 https://www.wockhardt.com/investor/appt-of-pramod-gupta-cfo-04-04-2022/ 2023-03-08T12:52:50+00:00 https://www.wockhardt.com/investor/restructuring-usa-20-08-2022/ 2023-03-08T12:54:12+00:00 https://www.wockhardt.com/investor/rpt-sept-2022/ 2023-03-11T04:27:09+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31-december-2022/ 2023-03-11T18:08:18+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30-september-2022/ 2023-03-11T18:10:07+00:00 https://www.wockhardt.com/investor/re-structuring-of-us-business-20th-august-2022/ 2023-03-11T18:40:12+00:00 https://www.wockhardt.com/investor/statement-on-deviation-or-variation-of-funds-raised-through-rights-issue-for-the-quarter-ended-30th-june-2022/ 2023-03-11T18:42:13+00:00 https://www.wockhardt.com/investor/annual-secretarial-compliance-report-for-the-year-ended-31st-march-2022/ 2023-03-11T18:44:47+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-04-11-2022/ 2023-03-11T18:45:40+00:00 https://www.wockhardt.com/investor/intimation-of-investors-call/ 2023-03-11T19:47:32+00:00 https://www.wockhardt.com/investor/investor-call-recording-february-2023/ 2023-03-11T19:58:00+00:00 https://www.wockhardt.com/investor/wockhardt-acquires-morton-grove-in-the-us/ 2023-03-22T06:02:52+00:00 https://www.wockhardt.com/investor/no-impact-of-derivatives-on-wockhardt/ 2023-03-22T06:10:30+00:00 https://www.wockhardt.com/investor/wockhardt-gets-us-fda-nod-to-market-ceftazidime-injections/ 2023-03-22T06:13:56+00:00 https://www.wockhardt.com/investor/wockhardt-launches-midazolam-in-the-us-market/ 2023-03-22T06:16:11+00:00 https://www.wockhardt.com/investor/wockhardt-takes-huge-strides-towards-in-licensing-and-collaborative-agreements/ 2023-03-22T06:16:31+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-generic-version-of-augmentin-suspension/ 2023-03-22T06:18:20+00:00 https://www.wockhardt.com/investor/wockhardt-signs-in-licensing-agreement-with-a-swiss-firm-for-bonistein/ 2023-03-22T06:26:57+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-divalproex-er-in-the-us-market/ 2023-03-22T08:01:10+00:00 https://www.wockhardt.com/investor/a-biotechnology-breakthrough-in-diabetes-wockhardt-launches-new-insulin-glaritus-in-india/ 2023-03-22T08:06:28+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-leveiracetam-a-generic-version-of-epilepsy-drug-in-the-us-market-2/ 2023-03-22T10:35:41+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-generic-version-of-migraine-drug-sumatriptan-in-the-us-market/ 2023-03-22T10:38:57+00:00 https://www.wockhardt.com/investor/harvard-medical-school-professor-shows-connection-of-cancer-and-heart-diseases-with-diabetes/ 2023-03-22T10:42:25+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-generic-version-of-ulcer-drug-ranitidine-syrup-in-the-us-market/ 2023-03-22T10:43:13+00:00 https://www.wockhardt.com/investor/vaccine-manufacturing-agreement-12-08-2021/ 2023-03-22T19:49:00+00:00 https://www.wockhardt.com/investor/financial-results-fy-2011-12-q3-oct-dec-2011/ 2023-03-23T06:34:13+00:00 https://www.wockhardt.com/investor/financial-results-fy-2011-12-q4-jan-mar-2012/ 2023-03-23T06:34:22+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q1-apr-jun-2012-0cc7f/ 2023-03-23T06:34:26+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-qualified-infectious-disease-product-designation-for-wck-6777-a-first-ever-once-a-day-ss-lactam-enhancer-class-antibiotic/ 2023-03-23T07:49:21+00:00 https://www.wockhardt.com/investor/wockhardt-gets-cdsco-nod-for-exporting-up-to-100-million-doses-of-spurik-vaccines/ 2023-03-23T13:08:26+00:00 https://www.wockhardt.com/investor/wockhardt-to-market-sammy-a-process-patented-tablet-for-osteoarthritis/ 2023-03-24T06:45:46+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-anti-epileptic-injection-fosphenytoin-in-the-us/ 2023-04-12T12:14:13+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2022/ 2023-04-12T12:19:57+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2021/ 2023-04-12T12:20:20+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2020/ 2023-04-12T12:21:11+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2019/ 2023-04-12T12:22:41+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2018/ 2023-04-12T12:23:25+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2017/ 2023-04-12T12:23:49+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2016/ 2023-04-12T12:24:14+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2015/ 2023-04-12T12:24:45+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2014/ 2023-04-12T12:25:17+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2013/ 2023-04-12T12:25:35+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2012/ 2023-04-12T12:26:09+00:00 https://www.wockhardt.com/investor/chairmains-agm-speech-2011/ 2023-04-12T12:26:38+00:00 https://www.wockhardt.com/investor/chairmains-agm-speech-2010/ 2023-04-12T12:27:26+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2009/ 2023-04-12T12:29:01+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2008/ 2023-04-12T12:30:19+00:00 https://www.wockhardt.com/investor/wockhardt-to-market-innovative-zindaclin-cream/ 2023-04-25T12:56:32+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q2-fy22-23/ 2023-05-05T12:11:48+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q3-fy22-23-2/ 2023-05-05T12:13:00+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q3-fy22-23/ 2023-05-05T12:14:43+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q1/ 2023-05-06T07:19:58+00:00 https://www.wockhardt.com/investor/financial-results-fy17-q2/ 2023-05-06T07:59:28+00:00 https://www.wockhardt.com/investor/financial-results-fy2016-17-q1-apr-jun-2016/ 2023-05-06T08:02:19+00:00 https://www.wockhardt.com/investor/financial-results-fy16-q3/ 2023-05-06T08:11:35+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-2015-16-2/ 2023-05-06T08:11:48+00:00 https://www.wockhardt.com/investor/rpt-6-12-21/ 2023-05-06T08:52:16+00:00 https://www.wockhardt.com/investor/financial-results-fy21-q4-2/ 2023-05-06T10:02:08+00:00 https://www.wockhardt.com/investor/financial-results-fy22-q4-2/ 2023-05-06T10:04:05+00:00 https://www.wockhardt.com/investor/related-party-transaction-report-for-mar-2020/ 2023-05-06T10:40:14+00:00 https://www.wockhardt.com/investor/related-party-transaction-report-for-sept-2020/ 2023-05-06T10:44:27+00:00 https://www.wockhardt.com/investor/related-party-transaction-report-for-sept-2019/ 2023-05-06T10:49:07+00:00 https://www.wockhardt.com/investor/related-party-transaction-report-for-mar-2019/ 2023-05-06T10:57:42+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30-september-2018/ 2023-05-12T10:35:40+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30-june-2019/ 2023-05-12T10:35:44+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31-march-2021/ 2023-05-12T10:35:48+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-31-march-2023/ 2023-05-12T10:35:53+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-year-ended-30-june-2022/ 2023-05-12T10:36:14+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-september-2018/ 2023-05-12T10:38:58+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-30th-june-2018/ 2023-05-12T10:40:08+00:00 https://www.wockhardt.com/investor/proceedings-of-agm/ 2023-05-12T11:23:29+00:00 https://www.wockhardt.com/investor/notice-2022/ 2023-05-12T12:18:41+00:00 https://www.wockhardt.com/investor/notice-2021/ 2023-05-12T12:20:07+00:00 https://www.wockhardt.com/investor/notice-2020/ 2023-05-12T12:20:23+00:00 https://www.wockhardt.com/investor/notice-2019/ 2023-05-12T12:20:39+00:00 https://www.wockhardt.com/investor/notice-2018/ 2023-05-12T12:21:06+00:00 https://www.wockhardt.com/investor/notice-2017/ 2023-05-12T12:21:26+00:00 https://www.wockhardt.com/investor/notice2016/ 2023-05-12T12:21:42+00:00 https://www.wockhardt.com/investor/notice-2015/ 2023-05-12T12:22:20+00:00 https://www.wockhardt.com/investor/notice-2014/ 2023-05-12T12:22:34+00:00 https://www.wockhardt.com/investor/notice-proposing-candidature-of-ms-tasneem-mehta-as-independent-director-under-section-160-of-the-companies-act-2013/ 2023-05-12T12:23:55+00:00 https://www.wockhardt.com/investor/agm/ 2023-05-12T12:24:12+00:00 https://www.wockhardt.com/investor/intimation-of-the-meeting-of-board-of-directors-13-feb-2023/ 2023-05-12T12:39:08+00:00 https://www.wockhardt.com/investor/investors-presentation-2022/ 2023-05-12T13:10:45+00:00 https://www.wockhardt.com/investor/investor-call-transcript-february-2023/ 2023-05-12T13:31:39+00:00 https://www.wockhardt.com/investor/investor-presentation-february-2023/ 2023-05-12T13:39:21+00:00 https://www.wockhardt.com/investor/india-rating-28-08-2019/ 2023-05-14T19:15:42+00:00 https://www.wockhardt.com/investor/care-rating-27-08-2020/ 2023-05-14T19:17:24+00:00 https://www.wockhardt.com/investor/india-rating-30-09-2020/ 2023-05-14T19:17:42+00:00 https://www.wockhardt.com/investor/care-rating-11-18/ 2023-05-14T19:18:53+00:00 https://www.wockhardt.com/investor/india-ratings-11-18/ 2023-05-14T19:19:08+00:00 https://www.wockhardt.com/investor/india-ratings-30-09-2021/ 2023-05-14T19:19:24+00:00 https://www.wockhardt.com/investor/india-rating-25-02-2020/ 2023-05-14T19:21:17+00:00 https://www.wockhardt.com/investor/credit-rating-intimataion-care-ratings-05-09-2022/ 2023-05-14T19:21:51+00:00 https://www.wockhardt.com/investor/credit-rating-intimataion-india-ratings-21-12-2022/ 2023-05-14T19:22:16+00:00 https://www.wockhardt.com/investor/care-rating-25-02-2020/ 2023-05-14T19:23:54+00:00 https://www.wockhardt.com/investor/shareholding-pattern-post-rights-issue-under-regulation-311c-of-sebi-lodr-regulations-2015/ 2023-05-22T07:34:11+00:00 https://www.wockhardt.com/investor/wockhardts-q1-fy23-ebitda-at-rs-16-cr-ebitda-before-rd-at-rs-20-c-2/ 2023-05-29T05:30:17+00:00 https://www.wockhardt.com/investor/wockhardts-q3-fy23-ebitda-growth-37-over-q2-fy23/ 2023-05-29T05:31:24+00:00 https://www.wockhardt.com/investor/wockhardt-announces-successful-initiation-of-global-phase-3-clinical-study-of-its-novel-antibiotic-wck-5222-16-aug-2022/ 2023-05-29T05:31:52+00:00 https://www.wockhardt.com/investor/wockhardts-q1-fy23-ebitda-at-rs-16-cr-ebitda-before-rd-at-rs-20-cr/ 2023-05-29T05:32:32+00:00 https://www.wockhardt.com/investor/wockhardts-fy22-revenue-grew-by-17-over-fy21-long-term-debt-reduced-by-rs-450-cr-successful-rights-issue-of-rs-748-cr/ 2023-05-29T05:32:57+00:00 https://www.wockhardt.com/investor/wockhardt-and-serum-life-sciences-uk-announce-collaboration-for-manufacturing-multiple-vaccines-in-the-united-kingdom/ 2023-05-29T05:33:31+00:00 https://www.wockhardt.com/investor/national-institutes-of-health-nih-usa-to-conduct-human-phase-1-trial-of-wockhardts-novel-once-a-day-mdr-gram-negative-antibiotic-wck-6777/ 2023-05-29T05:34:03+00:00 https://www.wockhardt.com/investor/wockhardt-gets-cdsco-nod-for-exporting-up-to-100-million-doses-of-spurik-vaccines-2/ 2023-05-29T05:34:56+00:00 https://www.wockhardt.com/investor/q3-oct-dec-2021-financial-results-fy22/ 2023-05-29T05:35:18+00:00 https://www.wockhardt.com/investor/q2-jul-sept-2021-financial-results-fy22/ 2023-05-29T05:35:35+00:00 https://www.wockhardt.com/investor/wockhardt-and-jemincare-partner-for-novel-respiratory-antibiotic-nafithromycin/ 2023-05-29T05:35:58+00:00 https://www.wockhardt.com/investor/rdif-and-wockhardt-partner-to-produce-sputnik-v-and-sputnik-light-vaccines-against-covid-19/ 2023-05-29T05:36:17+00:00 https://www.wockhardt.com/investor/hugely-successful-vaccination-roll-out-made-possible-by-uk-indian-business-partnership/ 2023-05-29T05:36:36+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2021-financial-results-fy22/ 2023-05-29T05:36:53+00:00 https://www.wockhardt.com/investor/wockhardt-uk-proudly-hosts-visit-of-hrh-the-prince-of-wales/ 2023-05-29T05:37:09+00:00 https://www.wockhardt.com/investor/q4-jan-mar-2021-financial-results-fy21/ 2023-05-29T05:37:24+00:00 https://www.wockhardt.com/investor/uk-government-announces-covid-19-vaccination-contract-extension-with-wockhardt/ 2023-05-29T06:18:35+00:00 https://www.wockhardt.com/investor/q3-oct-dec-2020-financial-results-fy21/ 2023-05-29T06:18:49+00:00 https://www.wockhardt.com/investor/q2-jul-sept-2020-financial-results-fy21/ 2023-05-29T06:19:23+00:00 https://www.wockhardt.com/investor/wockhardt-announces-the-appointment-of-mr-akhilesh-gupta-on-the-board/ 2023-05-29T06:20:02+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2020-financial-results-fy21/ 2023-05-29T06:20:15+00:00 https://www.wockhardt.com/investor/wockhardt-announces-covid-19-vaccine-partnership-with-uk-government/ 2023-05-29T06:20:24+00:00 https://www.wockhardt.com/investor/q4-jan-mar-2020-financial-results-fy20/ 2023-05-29T06:20:34+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-qualified-infectious-disease-product-designation-for-wck-6777-a-first-ever-once-a-day-ss-lactam-enhancer-class-antibiotic-2/ 2023-05-29T06:20:49+00:00 https://www.wockhardt.com/investor/wockhardt-to-raise-inr-1850-crore-by-sale-of-part-of-portfolio-of-its-domestic-branded-business-2/ 2023-05-29T06:21:42+00:00 https://www.wockhardt.com/investor/q3-oct-dec-2019-financial-results-fy20/ 2023-05-29T06:21:55+00:00 https://www.wockhardt.com/investor/indias-first-new-discovery-antibiotics-from-wockhardt-granted-indian-regulatory-approval/ 2023-05-29T06:22:04+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2019-financial-results-fy20/ 2023-05-29T06:22:12+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2019-financial-results-fy20-2/ 2023-05-29T06:22:21+00:00 https://www.wockhardt.com/investor/q4-jan-mar-2019-financial-results-fy19-2/ 2023-05-29T06:22:31+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-prostate-cancer-drug/ 2023-05-29T06:29:22+00:00 https://www.wockhardt.com/investor/q3-oct-dec-2018-financial-results-fy19-2/ 2023-05-29T06:29:40+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-leukemia-drug-2/ 2023-05-29T06:29:49+00:00 https://www.wockhardt.com/investor/q2-jul-sept-2018-financial-results-fy19-2/ 2023-05-29T06:30:00+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2018-financial-results-fy19-2/ 2023-05-29T06:30:10+00:00 https://www.wockhardt.com/investor/wockhardt-sets-up-its-first-manufacturing-and-rd-unit-in-middle-east/ 2023-05-29T06:30:23+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q4-jan-mar-2018-2/ 2023-05-29T06:30:35+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q3-oct-dec-2017-2/ 2023-05-29T06:30:44+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q2-jul-sept-2017-2/ 2023-05-29T06:33:18+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-antibiotic-injection/ 2023-05-29T06:33:28+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q1-apr-jun-2017/ 2023-05-29T06:33:40+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-eye-drop-for-treating-ophthalmic-allergies-3-july-2017/ 2023-05-29T06:33:52+00:00 https://www.wockhardt.com/investor/wockhardt-limited-and-its-subsidiaries-settle-with-teva-and-its-affiliate-a-commercial-litigation-in-the-high-court-london-2/ 2023-05-29T06:34:04+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q4-jan-mar-2017-2/ 2023-05-29T06:34:15+00:00 https://www.wockhardt.com/investor/wockhardt-receives-acknowledgement-of-its-breakthrough-superdrug-antibiotic-wck-5222-for-phase-iii-clinical-trial-from-us-fda/ 2023-05-29T06:34:32+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q3-oct-dec-2016-2/ 2023-05-29T06:35:33+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q2-jul-sept-2016-2/ 2023-05-29T06:35:45+00:00 https://www.wockhardt.com/investor/financial-results-fy2016-17-q1-apr-jun-2016-3/ 2023-05-29T06:35:55+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-2015-16-3/ 2023-05-29T06:36:03+00:00 https://www.wockhardt.com/investor/us-fda-grants-breakthrough-qidp-drug-discovery-status-to-the-new-antibiotic-of-wockhardt/ 2023-05-29T06:37:27+00:00 https://www.wockhardt.com/investor/financial-results-fy-2015-16-q2-jul-sep-2015-2/ 2023-05-29T06:37:37+00:00 https://www.wockhardt.com/investor/financial-results-fy-2015-16-q1-apr-jun-2015/ 2023-05-29T06:37:47+00:00 https://www.wockhardt.com/investor/wockhardt-receives-anda-approval-for-pain-medication-oxycodone-liquid/ 2023-05-29T06:38:00+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-14-15-2/ 2023-05-29T06:38:11+00:00 https://www.wockhardt.com/investor/wockhardt-receives-qidp-designation-for-its-new-drug-wck-4873-from-u-s-fda/ 2023-05-29T06:38:18+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q2-july-sept-2014-2/ 2023-05-29T06:39:51+00:00 https://www.wockhardt.com/investor/wockhardts-drug-discovery-gets-a-boost-with-fast-track-approval-by-usfda/ 2023-05-29T06:39:59+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-13-14-2/ 2023-05-29T06:40:07+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q2-jul-sept-2013-3/ 2023-05-29T06:40:55+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q1-apr-jun-2013-3/ 2023-05-29T06:41:06+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy12-13-2/ 2023-05-29T06:41:13+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q3-oct-dec-2012-3/ 2023-05-29T06:43:12+00:00 https://www.wockhardt.com/investor/wockhardt-receives-the-best-enterprise-award-from-the-europe-business-assembly/ 2023-05-29T06:43:21+00:00 https://www.wockhardt.com/investor/wockhardt-launches-generic-version-of-anti-convulsant-drug-lamictal-xr/ 2023-05-29T06:43:30+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q2-jul-sep-2012-3/ 2023-05-29T06:43:40+00:00 https://www.wockhardt.com/investor/wockhardt-launches-generic-version-of-anti-ulcer-drug-prevacid/ 2023-05-29T06:43:59+00:00 https://www.wockhardt.com/investor/wockhardt-launches-generic-version-of-antidepressant-drug-wellbutrin-sr/ 2023-05-29T06:44:10+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-generic-version-of-parkinsonism-drug-requip-xl/ 2023-05-29T06:44:18+00:00 https://www.wockhardt.com/investor/wockhardt-receives-tentative-us-fda-approval-for-generic-version-of-anti-psychotic-drug-gecdon/ 2023-05-29T06:44:27+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-generic-version-of-anti-hypertensive-drug-plendil/ 2023-05-29T06:44:34+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-generic-version-of-parkinsons-drug-comtan/ 2023-05-29T06:44:43+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-generic-version-of-clot-buster-drug-plavix/ 2023-05-29T06:44:52+00:00 https://www.wockhardt.com/investor/wockhardt-to-launch-generic-version-of-bph-drug-uroxatral/ 2023-05-29T06:45:05+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-qf-apr-jun-2012/ 2023-05-29T06:45:19+00:00 https://www.wockhardt.com/investor/wockhardt-honoured-with-2012-diana-award-for-best-overall-generic-manufacturer/ 2023-05-29T06:45:29+00:00 https://www.wockhardt.com/investor/wockhardt-launches-authorized-generic-of-parkinsons-drug-stalevo-with-180-days-exclusivity/ 2023-05-29T06:45:39+00:00 https://www.wockhardt.com/investor/wockhardt-receives-tentative-us-fda-approval-for-generic-version-of-depression-drug-cymbalta/ 2023-05-29T06:46:52+00:00 https://www.wockhardt.com/investor/wockhardt-receives-tentative-us-fda-approval-for-generic-version-of-patanol-ophthalmic-solution/ 2023-05-29T06:47:00+00:00 https://www.wockhardt.com/investor/wockhardt-launches-three-nev-products-in-three-weeks-in-the-united-states/ 2023-05-29T06:47:11+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-generic-version-of-aricept-tablets/ 2023-05-29T06:47:19+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-generic-version-of-effexor-xr-capsules/ 2023-05-29T06:47:28+00:00 https://www.wockhardt.com/investor/wockhardt-and-sheffield-bio-science-usa-announce-a-strategic-alliance-to-distribute-recombinant-insulin-in-cell-culture-markets-globally/ 2023-05-29T06:48:11+00:00 https://www.wockhardt.com/investor/wockhardt-launches-generic-version-of-protonix-tablets-in-the-us/ 2023-05-29T06:48:22+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-the-generic-version-of-allegra-d-12-hour/ 2023-05-29T06:48:32+00:00 https://www.wockhardt.com/investor/wockhardt-launches-anti-hypertensive-drug-nicardipine-injections-in-usa/ 2023-05-29T06:50:14+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-prostate-drug-alfuzosin-tablets/ 2023-05-29T06:50:26+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-prostate-drug-tamsulosin-capsules/ 2023-05-29T06:50:34+00:00 https://www.wockhardt.com/investor/wockhardt-wins-government-of-india-patent-award/ 2023-05-29T06:50:44+00:00 https://www.wockhardt.com/investor/wockhardt-divests-its-veterinary-business-to-vetoquinol/ 2023-05-29T06:50:52+00:00 https://www.wockhardt.com/investor/wockhardt-signs-agreements-to-divest-its-nutrition-businesses-to-abbott/ 2023-05-29T06:51:05+00:00 https://www.wockhardt.com/investor/wockhardt-signs-agreement-to-divest-its-animal-health-division/ 2023-05-29T06:51:13+00:00 https://www.wockhardt.com/investor/wockhardt-divests-its-german-business/ 2023-05-29T06:51:39+00:00 https://www.wockhardt.com/investor/wockhardt-appoints-bdo-haribhakti-as-auditor/ 2023-05-29T06:51:46+00:00 https://www.wockhardt.com/investor/wockhardt-announces-entacapone-patent-settlement-with-orion-corporation/ 2023-05-29T06:51:54+00:00 https://www.wockhardt.com/investor/wockhardt-announces-its-succession-plan-under-the-leadership-of-chairman-habil-khorakiwala/ 2023-05-29T06:52:02+00:00 https://www.wockhardt.com/investor/wockhardt-receives-us-fda-approval-for-cancer-drug/ 2023-05-29T06:54:08+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q1-apr-jun-2014-2/ 2023-05-29T06:55:28+00:00 https://www.wockhardt.com/investor/financial-results-fy21-2021-q1/ 2023-05-30T05:25:05+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q4/ 2023-05-30T05:25:59+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q3-2/ 2023-05-30T05:26:53+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q2-2/ 2023-05-30T05:27:05+00:00 https://www.wockhardt.com/investor/financial-results-fy-2019-20-q1-2/ 2023-05-30T05:27:14+00:00 https://www.wockhardt.com/investor/q4-jan-mar-2019-financial-results-fy19/ 2023-05-30T05:34:47+00:00 https://www.wockhardt.com/investor/q3-oct-dec-2018-financial-results-fy19/ 2023-05-30T05:35:12+00:00 https://www.wockhardt.com/investor/q2-jul-sept-2018-financial-results-fy19/ 2023-05-30T05:35:31+00:00 https://www.wockhardt.com/investor/q1-apr-jun-2018-financial-results-fy19/ 2023-05-30T05:35:41+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q4-jan-mar-2018/ 2023-05-30T05:36:03+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q3-oct-dec-2017/ 2023-05-30T05:36:20+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q2-jul-sept-2017/ 2023-05-30T05:36:32+00:00 https://www.wockhardt.com/investor/financial-results-fy-2017-18-q1-apr-jun-2017-b7aa1/ 2023-05-30T05:36:51+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q4-jan-mar-2017/ 2023-05-30T05:39:08+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q3-oct-dec-2016/ 2023-05-30T05:40:16+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q2-jul-sept-2016/ 2023-05-30T05:40:52+00:00 https://www.wockhardt.com/investor/financial-results-fy2016-17-q1-apr-jun-2016-2/ 2023-05-30T05:41:24+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-2015-16/ 2023-05-30T05:42:16+00:00 https://www.wockhardt.com/investor/financial-results-fy-2015-16-q2-jul-sep-2015/ 2023-05-30T05:43:05+00:00 https://www.wockhardt.com/investor/financial-results-fy-2015-16-q1-apr-jun-2015-3/ 2023-05-30T05:43:24+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-14-15/ 2023-05-30T05:43:46+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q3-oct-dec-2014-2/ 2023-05-30T05:44:13+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q2-july-sept-2014/ 2023-05-30T05:44:40+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q1-apr-jun-2014/ 2023-05-30T05:44:57+00:00 https://www.wockhardt.com/investor/wockhardt-annual-financial-results-fy-13-14/ 2023-05-30T05:45:28+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q2-jul-sept-2013/ 2023-05-30T05:46:40+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q1-apr-jun-2013-2/ 2023-05-30T05:46:57+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q3-oct-dec-2012/ 2023-05-30T05:47:16+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q2-jul-sep-2012/ 2023-05-30T05:47:31+00:00 https://www.wockhardt.com/investor/financial-results-fy-2012-13-q1-apr-jun-2012/ 2023-05-30T05:47:50+00:00 https://www.wockhardt.com/investor/wockhardts-financial-results-q4-jan-mar-fy-2011-12/ 2023-05-30T05:49:19+00:00 https://www.wockhardt.com/investor/wockhardts-financial-results-q3-oct-dec-fy-2011-12/ 2023-05-30T05:49:40+00:00 https://www.wockhardt.com/investor/wockhardts-financial-results-q2-jul-sept-fy-2011-12/ 2023-05-30T05:49:57+00:00 https://www.wockhardt.com/investor/wockhardts-financial-results-q1-april-june-fy-2011-12-64f03/ 2023-05-30T05:50:11+00:00 https://www.wockhardt.com/investor/wockhardts-q3-october-december-fy-2011-results-fcc99/ 2023-05-30T05:53:37+00:00 https://www.wockhardt.com/investor/wockhardts-q2-july-september-fy-2011/ 2023-05-30T05:53:53+00:00 https://www.wockhardt.com/investor/wockhardts-q1-apr-jun-fy-2011/ 2023-05-30T05:54:10+00:00 https://www.wockhardt.com/investor/wockhardts-q4-results-2009/ 2023-05-30T05:56:54+00:00 https://www.wockhardt.com/investor/wockhardts-q3-results-2009/ 2023-05-30T05:57:15+00:00 https://www.wockhardt.com/investor/wockhardts-q2-results-2009/ 2023-05-30T05:57:47+00:00 https://www.wockhardt.com/investor/wockhardts-q3-results-2008/ 2023-05-30T05:58:45+00:00 https://www.wockhardt.com/investor/wockhardts-q1-results-2008/ 2023-05-30T05:59:19+00:00 https://www.wockhardt.com/investor/wockhardts-q2-results-2008/ 2023-05-30T05:59:27+00:00 https://www.wockhardt.com/investor/wockhardts-q3-results-2007/ 2023-05-30T05:59:50+00:00 https://www.wockhardt.com/investor/financial-results-fy16-q3-2/ 2023-05-30T06:01:51+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q3-oct-dec-2013-2/ 2023-05-30T06:06:02+00:00 https://www.wockhardt.com/investor/wockhardt-hosts-visit-of-prime-minister-of-united-kingdom/ 2023-05-31T12:14:52+00:00 https://www.wockhardt.com/investor/model-tripartite-agreement-25-may-2023/ 2023-06-08T09:47:57+00:00 https://www.wockhardt.com/investor/financial-results-fy-2016-17-q2-oct-dec-15/ 2023-06-14T10:22:16+00:00 https://www.wockhardt.com/investor/financial-results-fy-2014-15-q3-oct-dec-2014/ 2023-06-14T10:29:52+00:00 https://www.wockhardt.com/investor/financial-results-fy-2013-14-q3-oct-dec-2013-3/ 2023-06-14T10:32:23+00:00 https://www.wockhardt.com/investor/wockhardts-q4-fy23-3-fold-jump-in-ebitda-over-q4-fy22/ 2023-06-14T10:49:32+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q4/ 2023-06-14T10:56:40+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-2/ 2023-06-14T11:02:16+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-18/ 2023-06-14T11:02:26+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q2-2/ 2023-06-21T08:02:45+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q3-2/ 2023-06-21T08:03:13+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q1-2/ 2023-06-21T08:03:24+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q3/ 2023-06-28T07:05:11+00:00 https://www.wockhardt.com/investor/financial-results-fy23-q2/ 2023-06-28T07:05:26+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q4-fy22-23/ 2023-06-28T09:24:35+00:00 https://www.wockhardt.com/investor/acceptable-usage-policy-for-it-systems/ 2023-07-13T13:09:03+00:00 https://www.wockhardt.com/investor/code-of-business-conduct-and-ethics/ 2023-07-14T07:53:05+00:00 https://www.wockhardt.com/investor/form-mgt-7/ 2023-07-20T13:13:11+00:00 https://www.wockhardt.com/investor/secretarial-auditors-compliance-certificate-on-implementation-of-esos-scheme/ 2023-07-20T13:20:55+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-june-30-2023/ 2023-07-20T13:41:04+00:00 https://www.wockhardt.com/investor/wockhardt-bio-pty-ltd-6/ 2023-07-21T10:04:58+00:00 https://www.wockhardt.com/investor/wockhardt-bio-r-llc-2/ 2023-07-21T10:06:23+00:00 https://www.wockhardt.com/investor/wockhardt-services-sa-de-cv-8/ 2023-07-21T10:11:21+00:00 https://www.wockhardt.com/investor/wockhardt-holding-corp-3/ 2023-07-21T10:13:10+00:00 https://www.wockhardt.com/investor/pinewood-healthcare-limited-6/ 2023-07-21T10:18:32+00:00 https://www.wockhardt.com/investor/cp-pharma-schweiz-ag-9/ 2023-07-21T10:23:20+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-do-brasil-ltda-6/ 2023-07-21T10:24:55+00:00 https://www.wockhardt.com/investor/wallis-licensing-limited-7/ 2023-07-21T10:25:50+00:00 https://www.wockhardt.com/investor/wockhardt-europe-limited-7/ 2023-07-21T10:29:21+00:00 https://www.wockhardt.com/investor/wockhardt-bio-ag-8/ 2023-07-21T10:29:53+00:00 https://www.wockhardt.com/investor/wockhardt-biologics-limited/ 2023-07-21T10:31:10+00:00 https://www.wockhardt.com/investor/wockhardt-medicines-limited-4/ 2023-07-21T10:32:36+00:00 https://www.wockhardt.com/investor/wockhardt-infrastucture-development-limited/ 2023-07-21T10:33:20+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-sa-de-cv-5/ 2023-07-21T12:03:47+00:00 https://www.wockhardt.com/investor/annual-report-2022-2023/ 2023-07-21T13:27:53+00:00 https://www.wockhardt.com/investor/notice-2023/ 2023-07-21T13:33:04+00:00 https://www.wockhardt.com/investor/secretarial-auditors-compliance-certificate-on-implementation-of-esos-scheme-2/ 2023-07-22T15:15:19+00:00 https://www.wockhardt.com/investor/laboratoires-negma-s-a/ 2023-08-02T14:10:54+00:00 https://www.wockhardt.com/investor/wockpharma-ireland-limited-7/ 2023-08-02T14:14:00+00:00 https://www.wockhardt.com/investor/wockhardt-france-holdings-s-a-s-6/ 2023-08-02T14:15:22+00:00 https://www.wockhardt.com/investor/wockhardt-europe-limited-8/ 2023-08-07T05:30:47+00:00 https://www.wockhardt.com/investor/cp-pharma-schweiz-ag-10/ 2023-08-07T05:31:17+00:00 https://www.wockhardt.com/investor/wallis-group-limited-6/ 2023-08-07T05:31:25+00:00 https://www.wockhardt.com/investor/the-wallis-laboratory-limited-7/ 2023-08-07T05:31:31+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-do-brasil-ltda-7/ 2023-08-07T05:31:50+00:00 https://www.wockhardt.com/investor/wallis-licensing-limited-8/ 2023-08-07T05:32:02+00:00 https://www.wockhardt.com/investor/wockhardt-holding-corp-4/ 2023-08-07T05:32:10+00:00 https://www.wockhardt.com/investor/wockhardt-bio-ag-9/ 2023-08-07T05:32:17+00:00 https://www.wockhardt.com/investor/wockhardt-uk-limited-7/ 2023-08-07T05:32:27+00:00 https://www.wockhardt.com/investor/wockpharma-ireland-limited-8/ 2023-08-07T05:32:36+00:00 https://www.wockhardt.com/investor/pinewood-laboratories-limited-10/ 2023-08-07T05:32:44+00:00 https://www.wockhardt.com/investor/niverpharma-s-a-s-5/ 2023-08-07T05:33:08+00:00 https://www.wockhardt.com/investor/negma-beneulex-s-a-3/ 2023-08-07T05:33:52+00:00 https://www.wockhardt.com/investor/wockhardt-services-sa-de-cv-9/ 2023-08-07T05:34:15+00:00 https://www.wockhardt.com/investor/pinewood-healthcare-limited-7/ 2023-08-07T05:34:28+00:00 https://www.wockhardt.com/investor/wockhardt-bio-r-llc-3/ 2023-08-07T05:34:35+00:00 https://www.wockhardt.com/investor/wockhardt-bio-pty-ltd-7/ 2023-08-07T05:34:46+00:00 https://www.wockhardt.com/investor/z-z-services-gmbh-5/ 2023-08-07T07:49:01+00:00 https://www.wockhardt.com/investor/wockhardt-france-holdings-s-a-s-7/ 2023-08-09T10:46:37+00:00 https://www.wockhardt.com/investor/laboratoires-pharma-2000-s-a-s-6/ 2023-08-09T10:48:10+00:00 https://www.wockhardt.com/investor/laboratoires-negma-s-a-s-8/ 2023-08-09T10:48:50+00:00 https://www.wockhardt.com/investor/phytex-s-a/ 2023-08-09T10:49:20+00:00 https://www.wockhardt.com/investor/ockhardt-farmaceutica-sa-de-cv/ 2023-08-09T10:49:46+00:00 https://www.wockhardt.com/investor/wockhardt-nigeria-limited-7/ 2023-08-09T11:04:36+00:00 https://www.wockhardt.com/investor/wockhardt-uk-holdings-limited-9/ 2023-08-09T11:05:06+00:00 https://www.wockhardt.com/investor/c-p-pharmaceuticals-limited-3/ 2023-08-09T11:13:58+00:00 https://www.wockhardt.com/investor/the-wallis-laboratory-limited-6/ 2023-08-09T15:59:15+00:00 https://www.wockhardt.com/investor/allis-group-limited/ 2023-08-09T16:38:48+00:00 https://www.wockhardt.com/investor/wockhardt-uk-holdings-limited-8/ 2023-08-09T16:39:48+00:00 https://www.wockhardt.com/investor/wockhardt-uk-limited-8/ 2023-08-09T16:42:05+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-3/ 2023-08-14T13:33:41+00:00 https://www.wockhardt.com/investor/wockhardts-q1-fy24-3-fold-growth-in-ebitda-over-q1-fy23/ 2023-08-14T13:35:35+00:00 https://www.wockhardt.com/investor/financial-results-fy24-q1/ 2023-08-14T13:37:23+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2023/ 2023-08-16T06:06:56+00:00 https://www.wockhardt.com/investor/proceedings-of-agm-2/ 2023-08-16T06:08:49+00:00 https://www.wockhardt.com/investor/voting-results-and-scrutinizers-report-24th-agm/ 2023-08-18T11:40:03+00:00 https://www.wockhardt.com/investor/voting-results-and-scrutinizers-report-23rd-agm/ 2023-08-18T11:53:09+00:00 https://www.wockhardt.com/investor/24th-agm-transcript/ 2023-08-25T10:31:52+00:00 https://www.wockhardt.com/investor/credit-rating-intimation-care-ratings-05-09-2023/ 2023-09-08T04:55:55+00:00 https://www.wockhardt.com/investor/wockhardts-q4-fy23-3-fold-jump-in-ebitda-over-q4-fy22-2/ 2023-10-11T10:08:31+00:00 https://www.wockhardt.com/investor/wockhardts-q1-fy24-3-fold-growth-in-ebitda-over-q1-fy23-2/ 2023-10-11T10:11:21+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-september-30-2023/ 2023-10-20T12:22:00+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-4-november-2023/ 2023-11-14T10:08:52+00:00 https://www.wockhardt.com/investor/financial-results-fy24-q2/ 2023-11-14T10:15:41+00:00 https://www.wockhardt.com/investor/wockhardt-reports-an-excellent-quarter-q2-revenue-jumps-by-11/ 2023-11-14T13:36:22+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q2-fy23-24/ 2023-11-29T11:14:58+00:00 https://www.wockhardt.com/investor/link-name-wockhardt-announces-successful-completion-of-pivotal-phase-3-pneumonia-study-of-its-macrolide-antibiotic-nafithromycin-wck-4873/ 2023-12-11T08:27:57+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-december-31-2023/ 2024-01-30T12:12:14+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-19/ 2024-02-06T12:01:34+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-20/ 2024-02-06T12:02:31+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-21/ 2024-02-06T12:03:20+00:00 https://www.wockhardt.com/investor/appointment-of-ms-amelia-fernandes-as-additional-independent-director-of-the-company/ 2024-02-06T12:07:14+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-4/ 2024-02-14T12:45:08+00:00 https://www.wockhardt.com/investor/wockhardts-ebitda-at-rs-173-crore-yoy-growth-80-2/ 2024-02-14T12:53:59+00:00 https://www.wockhardt.com/investor/wockhardts-ebitda-at-rs-173-crore-yoy-growth-80/ 2024-02-14T12:55:29+00:00 https://www.wockhardt.com/investor/financial-results-fy24-q3/ 2024-02-14T12:57:32+00:00 https://www.wockhardt.com/investor/investor-presentation-february-2024/ 2024-02-26T06:54:10+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q3-fy23-24/ 2024-02-28T12:55:12+00:00 https://www.wockhardt.com/investor/a-leading-european-journal-reports-renal-transplant-patients-unique-clinical-case-of-successful-use-of-zidebactam-cefepime-wck-5222-zaynichtm-to-treat-skull-bone-infection-pneumonia-caus/ 2024-03-11T10:07:22+00:00 https://www.wockhardt.com/investor/a-leading-european-journal-reports-renal-transplant-patients-unique-clinical-case-of-successful-use-of-zidebactam-cefepime-wck-5222-zaynichtm-to-treat-skull-bone-infection-pneumonia-caus-2/ 2024-03-11T10:09:12+00:00 https://www.wockhardt.com/investor/preliminary-placement-document/ 2024-03-23T12:38:57+00:00 https://www.wockhardt.com/investor/shareholding-pattern-post-allotment-of-equity-shares-by-way-of-qip/ 2024-03-27T10:17:08+00:00 https://www.wockhardt.com/investor/placement-document/ 2024-03-28T12:20:39+00:00 https://www.wockhardt.com/investor/intimation-of-completion-of-tenure-of-independent-directors-of-the-company/ 2024-04-05T11:05:49+00:00 https://www.wockhardt.com/investor/disclosure-of-completion-of-tenure-of-independent-directors-of-the-company/ 2024-04-05T11:06:04+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-march-31-2024/ 2024-04-22T10:09:03+00:00 https://www.wockhardt.com/investor/rpt-march-2023/ 2024-05-07T07:31:16+00:00 https://www.wockhardt.com/investor/credit-rating-by-icra-limited-15-may-2024/ 2024-05-15T13:21:31+00:00 https://www.wockhardt.com/investor/secretarial-auditors-compliance-certificate-on-implementation-of-esos-scheme-3/ 2024-05-22T07:45:32+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-22/ 2024-05-23T06:48:01+00:00 https://www.wockhardt.com/investor/zidebactam-cefepime-wck-5222-update/ 2024-05-28T17:09:13+00:00 https://www.wockhardt.com/investor/zidebactam-cefepime-wck-5222-update-2/ 2024-05-28T17:11:16+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-5/ 2024-05-28T17:31:27+00:00 https://www.wockhardt.com/investor/wockhardts-ebitda-at-rs-251-crore-yoy-growth-74/ 2024-05-28T17:32:25+00:00 https://www.wockhardt.com/investor/notice-2024/ 2024-06-06T10:34:29+00:00 https://www.wockhardt.com/investor/annual-report-2023-2024/ 2024-06-06T10:35:33+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q4-fy23-24/ 2024-06-06T13:09:54+00:00 https://www.wockhardt.com/investor/annual-return-2023-2024/ 2024-06-07T06:40:16+00:00 https://www.wockhardt.com/investor/newspaper-extracts-public-notice-to-the-shareholders-of-the-company/ 2024-06-07T12:28:24+00:00 https://www.wockhardt.com/investor/wockhardt-europe-limited-9/ 2024-06-10T06:49:34+00:00 https://www.wockhardt.com/investor/wockhardt-nigeria-limited-6/ 2024-06-11T10:37:40+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-sa-de-cv-6/ 2024-06-11T10:38:45+00:00 https://www.wockhardt.com/investor/wockhardt-services-sa-de-cv-10/ 2024-06-11T10:39:28+00:00 https://www.wockhardt.com/investor/wockhardt-bio-pty-ltd-8/ 2024-06-11T10:40:05+00:00 https://www.wockhardt.com/investor/wockhardt-bionova-limited/ 2024-06-11T10:45:14+00:00 https://www.wockhardt.com/investor/wockhardt-holding-corp-5/ 2024-06-11T10:45:41+00:00 https://www.wockhardt.com/investor/cp-pharma-schweiz-ag-11/ 2024-06-14T13:19:06+00:00 https://www.wockhardt.com/investor/wockhardt-bio-r-llc-4/ 2024-06-17T12:26:56+00:00 https://www.wockhardt.com/investor/wockhardt-medicines-limited-5/ 2024-06-18T13:02:23+00:00 https://www.wockhardt.com/investor/zz-services-gmbh-5/ 2024-06-20T13:11:34+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-do-brasil-ltda-8/ 2024-06-20T13:12:20+00:00 https://www.wockhardt.com/investor/wockhardt-bio-ag-10/ 2024-06-27T05:55:12+00:00 https://www.wockhardt.com/investor/globally-renowned-us-body-clinical-and-laboratory-standards-institute-clsi-awards-high-susceptibility-breakpoints-to-zaynich-zidebactam-cefepime-wck-5222/ 2024-06-28T11:38:40+00:00 https://www.wockhardt.com/investor/successful-use-of-investigational-antibiotic-zaynich-zidebactam-cefepime-wck-5222-to-treat-a-cancer-patient-in-us-with-chronic-bilateral-thigh-infection-caused-by-an-extreme-drug-resistant-pseudomo/ 2024-06-28T11:40:19+00:00 https://www.wockhardt.com/investor/globally-renowned-us-body-clinical-and-laboratory-standards-institute-clsi-awards-high-susceptibility-breakpoints-to-zaynich-zidebactam-cefepime-wck-5222-2/ 2024-06-28T13:52:25+00:00 https://www.wockhardt.com/investor/successful-use-of-investigational-antibiotic-zaynich-zidebactam-cefepime-wck-5222-to-treat-a-cancer-patient-in-us-with-chronic-bilateral-thigh-infection-caused-by-an-extreme-drug-resistant-pseudomo-2/ 2024-06-28T13:54:02+00:00 https://www.wockhardt.com/investor/proceedings-of-agm-3/ 2024-06-28T13:57:16+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2024/ 2024-06-28T14:04:07+00:00 https://www.wockhardt.com/investor/25th-agm-transcript/ 2024-07-02T12:22:49+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-june-30-2024/ 2024-07-25T07:17:00+00:00 https://www.wockhardt.com/investor/board-meeting-intimation-23/ 2024-08-07T11:33:15+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-6/ 2024-08-09T11:53:51+00:00 https://www.wockhardt.com/investor/financial-results-fy25-q1/ 2024-08-09T11:56:20+00:00 https://www.wockhardt.com/investor/financial-results-fy24-q4/ 2024-08-09T11:57:25+00:00 https://www.wockhardt.com/investor/3-fold-growth-in-wockhardts-ebitda-at-rs-100-crore/ 2024-08-09T13:04:12+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q1-fy24-25/ 2024-08-26T05:41:40+00:00 https://www.wockhardt.com/investor/cp-pharma-31-03-2024/ 2024-08-27T07:10:23+00:00 https://www.wockhardt.com/investor/wock-uk-31-03-2024/ 2024-08-27T07:12:15+00:00 https://www.wockhardt.com/investor/pinewood-laboratories-limited-11/ 2024-08-30T13:19:11+00:00 https://www.wockhardt.com/investor/wockpharma-ireland-limited-9/ 2024-08-30T13:19:33+00:00 https://www.wockhardt.com/investor/clarification-dated-6th-september-2024/ 2024-09-06T16:23:50+00:00 https://www.wockhardt.com/investor/wockhardt-wins-prestigious-innovator-award-from-government-of-india/ 2024-09-16T05:48:38+00:00 https://www.wockhardt.com/investor/wockhardt-wins-prestigious-innovator-award-from-government-of-india-2/ 2024-09-16T05:50:03+00:00 https://www.wockhardt.com/investor/intimation-under-regulation-30/ 2024-09-16T10:03:54+00:00 https://www.wockhardt.com/investor/wockhardts-investigational-drug-zaynich-zidebactam-cefepime-cures-complex-case-of-meningitis-caused-by-pan-drug-resistant-super-bug-under-compassionate-use/ 2024-09-23T08:08:43+00:00 https://www.wockhardt.com/investor/dr-habil-khorakiwala-bestowed-lifetime-achievement-award-by-integrated-health-and-wellbeing-council-in-dubai/ 2024-09-23T12:29:33+00:00 https://www.wockhardt.com/investor/dr-habil-khorakiwala-bestowed-lifetime-achievement-award-by-integrated-health-and-wellbeing-council-in-dubai-2/ 2024-09-23T12:32:04+00:00 https://www.wockhardt.com/investor/wockhardts-investigational-drug-zaynich-zidebactam-cefepime-cures-complex-case-of-meningitis-caused-by-pan-drug-resistant-super-bug-under-compassionate-use-2/ 2024-09-26T07:54:41+00:00 https://www.wockhardt.com/investor/disclosure-of-completion-of-tenure-of-independent-director-of-the-company/ 2024-10-01T10:52:24+00:00 https://www.wockhardt.com/investor/wockhardts-another-breakthrough-antibiotic-once-a-day-%ce%b2-lactam-enhancer-wck-6777-with-unique-out-patient-treatment-advantage-granted-fast-track-designation-by-us-fda-and-successfully-co/ 2024-10-07T06:36:27+00:00 https://www.wockhardt.com/investor/wockhardts-another-breakthrough-antibiotic-once-a-day-%ce%b2-lactam-enhancer-wck-6777-with-unique-out-patient-treatment-advantage-granted-fast-track-designation-by-us-fda-and-successfully-complete/ 2024-10-07T06:40:40+00:00 https://www.wockhardt.com/investor/committees-of-board-and-its-composition/ 2024-10-11T06:28:59+00:00 https://www.wockhardt.com/investor/wockhardts-yet-another-novel-antibiotic-miqnaftm-nafithromycin-receives-favourable-recommendation-from-subject-expert-committee-of-central-drugs-standard-control-organization-cdsco-for-th/ 2024-10-11T11:51:14+00:00 https://www.wockhardt.com/investor/wockhardts-yet-another-novel-antibiotic-miqnaftm-nafithromycin-receives-favourable-recommendation-from-subject-expert-committee-of-central-drugs-standard-control-organization-cdsco-for-th-2/ 2024-10-16T06:48:15+00:00 https://www.wockhardt.com/investor/wockhardt-files-fast-acting-insulin-aspart-injection-asparapidtm-with-dcgi-strengthens-commitment-to-diabetes-management/ 2024-10-16T06:49:45+00:00 https://www.wockhardt.com/investor/wockhardt-files-fast-acting-insulin-aspart-injection-asparapidtm-with-dcgi-strengthens-commitment-to-diabetes-management-2/ 2024-10-16T06:51:35+00:00 https://www.wockhardt.com/investor/investor-presentation-october-2024-october/ 2024-10-21T03:32:32+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-september-30-2024/ 2024-10-24T12:36:33+00:00 https://www.wockhardt.com/investor/pinewood-healthcare-limited-8/ 2024-10-24T13:20:34+00:00 https://www.wockhardt.com/investor/wockhardt-infrastructure-development-limited-9/ 2024-10-24T13:22:38+00:00 https://www.wockhardt.com/investor/wockhardt-uk-holdings-limited-consolidated/ 2024-10-24T13:25:19+00:00 https://www.wockhardt.com/investor/wallis-group-2/ 2024-10-24T13:34:17+00:00 https://www.wockhardt.com/investor/wallis-laboratory/ 2024-10-24T13:36:05+00:00 https://www.wockhardt.com/investor/wallis-licensing-3/ 2024-10-24T13:40:50+00:00 https://www.wockhardt.com/investor/wockhardt-france-holdings-s-a-s-consolidated/ 2024-10-30T14:34:21+00:00 https://www.wockhardt.com/investor/preliminary-placement-document-2/ 2024-11-07T18:29:31+00:00 https://www.wockhardt.com/investor/placement-document-2/ 2024-11-11T18:56:15+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-7/ 2024-11-13T09:50:58+00:00 https://www.wockhardt.com/investor/financial-results-fy25-q2/ 2024-11-13T12:52:18+00:00 https://www.wockhardt.com/investor/h1fy25-ebitda-at-rs-239-crore-growth-by-112/ 2024-11-13T16:21:18+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q2-fy24-25/ 2024-11-19T05:45:29+00:00 https://www.wockhardt.com/investor/wl-rpt-march-2024/ 2024-12-02T11:48:50+00:00 https://www.wockhardt.com/investor/rpt-september-2023/ 2024-12-02T11:50:57+00:00 https://www.wockhardt.com/investor/rpt-september-2024/ 2024-12-02T11:52:59+00:00 https://www.wockhardt.com/investor/zaynich-zidebactam-cefepime-wck-5222-enables-us-cancer-patient-undergo-successful-liver-transplant-and-resume-chemotherapy-by-eradicating-dual-extreme-drug-resistant-gram-negative-pathog/ 2024-12-16T05:11:16+00:00 https://www.wockhardt.com/investor/indian-drug-regulator-approves-wockhardts-new-generation-oral-antibiotic-miqnaf-nafithromycin-for-the-treatment-of-community-acquired-bacterial-pneumonia-cabp/ 2025-01-02T15:42:53+00:00 https://www.wockhardt.com/investor/indian-drug-regulator-approves-wockhardts-new-generation-oral-antibiotic-miqnaf-nafithromycin-for-the-treatment-of-community-acquired-bacterial-pneumonia-cabp-2/ 2025-01-06T07:53:59+00:00 https://www.wockhardt.com/investor/zaynich-zidebactam-cefepime-wck-5222-achieves-over-97-efficacy-in-clinical-study-for-serious-infections-caused-by-meropenem-resistant-gram-negative-pathogens/ 2025-01-13T05:04:35+00:00 https://www.wockhardt.com/investor/zaynich-zidebactam-cefepime-wck-5222-achieves-over-97-efficacy-in-clinical-study-for-serious-infections-caused-by-meropenem-resistant-gram-negative-pathogens-2/ 2025-01-13T05:06:39+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-december-31-2024/ 2025-01-21T09:18:08+00:00 https://www.wockhardt.com/investor/financial-results-fy25-q3/ 2025-02-07T08:55:00+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-8/ 2025-02-07T08:56:17+00:00 https://www.wockhardt.com/investor/9mfy25-ebitda-at-rs-339-crore-growth-by-89/ 2025-02-07T11:33:46+00:00 https://www.wockhardt.com/investor/wockhardts-ebitda-at-rs-251-crore-yoy-growth-74-2/ 2025-02-08T10:24:46+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q3-fy24-25/ 2025-02-14T07:14:10+00:00 https://www.wockhardt.com/investor/wockhardts-zaynich-zidebactam-cefepime-wck-5222-achieves-highest-ever-efficacy-meeting-superiority-in-a-global-pivotal-registration-enabling-phase-iii-study-in-complicated-urin/ 2025-03-06T13:27:38+00:00 https://www.wockhardt.com/investor/paediatric-us-cancer-patient-with-recalcitrant-blood-and-liver-infection-successfully-treated-with-zaynich-zidebactam-cefepime-wck-5222/ 2025-04-01T04:07:45+00:00 https://www.wockhardt.com/investor/paediatric-us-cancer-patient-with-recalcitrant-blood-and-liver-infection-successfully-treated-with-zaynich-zidebactam-cefepime-wck-5222-2/ 2025-04-01T04:09:45+00:00 https://www.wockhardt.com/investor/intimation-for-incorporation-of-a-step-down-subsidiary-company/ 2025-04-09T10:03:28+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-march-31-2025/ 2025-04-22T09:42:37+00:00 https://www.wockhardt.com/investor/secretarial-auditors-compliance-certificate-on-implementation-of-esos-scheme-4/ 2025-05-22T10:40:37+00:00 https://www.wockhardt.com/investor/financial-results-fy25-q4/ 2025-05-29T10:34:14+00:00 https://www.wockhardt.com/investor/outcome-of-q4-fy24-25-board-meeting/ 2025-05-29T10:44:18+00:00 https://www.wockhardt.com/investor/audited-financial-results-standalone-and-consolidated-for-the-quarter-and-the-financial-year-ended-31st/ 2025-05-29T12:41:15+00:00 https://www.wockhardt.com/investor/audited-financial-results-standalone-and-consolidated-for-the-quarter-and-the-financial-year-ended-31st-march-2025/ 2025-05-29T12:41:26+00:00 https://www.wockhardt.com/investor/intimation-of-schedule-of-investors-meeting-call-on-5th-june-2025/ 2025-06-02T17:09:39+00:00 https://www.wockhardt.com/investor/newspaper-advertisement-in-business-standard-q4-fy-24-25/ 2025-06-03T06:23:44+00:00 https://www.wockhardt.com/investor/newspaper-advertisement-in-nav-shakti-q4-fy-24-25/ 2025-06-03T06:26:36+00:00 https://www.wockhardt.com/investor/investor-presentation-june-2025/ 2025-06-05T03:46:43+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q4-fy24-25/ 2025-06-09T13:25:30+00:00 https://www.wockhardt.com/investor/investor-call-transcript-june-2025/ 2025-06-11T11:54:41+00:00 https://www.wockhardt.com/investor/pinewood-laboratories-limited-12/ 2025-06-30T07:32:23+00:00 https://www.wockhardt.com/investor/wockpharma-ireland-limited-10/ 2025-06-30T07:33:32+00:00 https://www.wockhardt.com/investor/wockhardt-bio-ag-11/ 2025-07-03T09:23:21+00:00 https://www.wockhardt.com/investor/wockhardt-initiates-strategic-realignment-of-us-operations-to-focus-on-innovative-portfolio/ 2025-07-11T11:50:58+00:00 https://www.wockhardt.com/investor/wockhardt-initiates-strategic-realignment-of-us-operations-to-focus-on-innovative-portfolio-2/ 2025-07-11T11:53:55+00:00 https://www.wockhardt.com/investor/notice-2025/ 2025-07-16T11:45:52+00:00 https://www.wockhardt.com/investor/annual-report-2024-2025/ 2025-07-16T14:25:43+00:00 https://www.wockhardt.com/investor/zz-service-gmbh/ 2025-07-18T07:22:10+00:00 https://www.wockhardt.com/investor/wockhardt-medicines-limited-6/ 2025-07-18T07:28:07+00:00 https://www.wockhardt.com/investor/cp-pharma-switzerland-ltd/ 2025-07-18T07:30:20+00:00 https://www.wockhardt.com/investor/wockhardt-bio-pty-ltd-9/ 2025-07-18T07:59:21+00:00 https://www.wockhardt.com/investor/wockhardt-bionova-limited-2/ 2025-07-18T07:59:46+00:00 https://www.wockhardt.com/investor/wockhardt-europe-limited-10/ 2025-07-18T08:00:19+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-do-brasil-ltda-9/ 2025-07-18T08:00:39+00:00 https://www.wockhardt.com/investor/wockhardt-farmaceutica-sa-de-cv-7/ 2025-07-18T08:00:59+00:00 https://www.wockhardt.com/investor/wockhardt-nigeria-limited-8/ 2025-07-18T08:01:10+00:00 https://www.wockhardt.com/investor/wockhardt-services-sa-de-c/ 2025-07-18T08:01:20+00:00 https://www.wockhardt.com/investor/wockhardt-holding-corp-6/ 2025-07-18T08:09:26+00:00 https://www.wockhardt.com/investor/newspaper-extracts-public-notice-to-the-shareholders-of-the-company-2/ 2025-07-18T11:53:33+00:00 https://www.wockhardt.com/investor/wockhardt-bio-r-llc-5/ 2025-07-21T11:51:05+00:00 https://www.wockhardt.com/investor/wockhardt-infrastructure-development-limited-10/ 2025-07-24T12:46:19+00:00 https://www.wockhardt.com/investor/leading-u-k-medical-journal-publishes-a-complex-case-of-severe-pan-drug-resistant-infection-in-u-s-liver-transplant-patient-successfully-treated-with-zaynich-zidebactam-cefepime-wck-5222-2/ 2025-07-28T04:38:13+00:00 https://www.wockhardt.com/investor/leading-u-k-medical-journal-publishes-a-complex-case-of-severe-pan-drug-resistant-infection-in-u-s-liver-transplant-patient-successfully-treated-with-zaynich-zidebactam-cefepime-wck-5222/ 2025-07-28T04:39:06+00:00 https://www.wockhardt.com/investor/wockhardt-agm-key-resolution-rationale/ 2025-07-30T11:07:57+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-9/ 2025-08-08T08:52:43+00:00 https://www.wockhardt.com/investor/wockhardt-q1-fy26-highlights/ 2025-08-08T09:43:16+00:00 https://www.wockhardt.com/investor/chairmans-agm-speech-2025/ 2025-08-08T11:59:32+00:00 https://www.wockhardt.com/investor/financial-results-fy26-q1/ 2025-08-08T12:08:55+00:00 https://www.wockhardt.com/investor/proceedings-of-agm-4/ 2025-08-08T15:57:24+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-june-30-2025/ 2025-08-13T13:19:41+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q1-fy25-26/ 2025-08-14T07:39:07+00:00 https://www.wockhardt.com/investor/26th-agm-transcript/ 2025-08-14T11:18:08+00:00 https://www.wockhardt.com/investor/prestigious-medical-and-public-health-journal-the-lancet-regional-health-publishes-pivotal-phase-3-clinical-study-on-miqnaf-nafithromycin-a-landmark-for-india/ 2025-09-25T11:19:47+00:00 https://www.wockhardt.com/investor/prestigious-medical-and-public-health-journal-the-lancet-regional-health-publishes-pivotal-phase-3-clinical-study-on-miqnaf-nafithromycin-a-landmark-for-india-2/ 2025-09-26T07:54:46+00:00 https://www.wockhardt.com/investor/annual-return-2024-2025/ 2025-09-29T10:33:52+00:00 https://www.wockhardt.com/investor/news-paper-extract-notice-to-shareholders-regarding-special-window-for-re-lodgement-of-transfer-of-physical-shares-sept-2025/ 2025-09-29T12:28:25+00:00 https://www.wockhardt.com/investor/newspaper-extract-notice-to-shareholders-regarding-special-window-for-re-lodgement-of-transfer-of-physical-shares-july-2025/ 2025-09-29T12:33:54+00:00 https://www.wockhardt.com/investor/wockhardt-submits-new-drug-application-to-u-s-fda-for-zidebactam-cefepime-wck-5222-for-treatment-of-serious-gram-negative-infections-2/ 2025-10-01T06:21:58+00:00 https://www.wockhardt.com/investor/wockhardt-submits-new-drug-application-to-u-s-fda-for-zidebactam-cefepime-wck-5222-for-treatment-of-serious-gram-negative-infections/ 2025-10-01T08:17:01+00:00 https://www.wockhardt.com/investor/cp-pharmaceuticals-ltd/ 2025-10-14T12:10:47+00:00 https://www.wockhardt.com/investor/wockhardt-uk-ltd/ 2025-10-14T12:12:00+00:00 https://www.wockhardt.com/investor/shareholding-pattern-for-the-quarter-ended-september-30-2025/ 2025-10-24T12:23:04+00:00 https://www.wockhardt.com/investor/wockhardt-reports-positive-pbt-in-q2fy26-inr-91-crore/ 2025-11-03T10:45:49+00:00 https://www.wockhardt.com/investor/outcome-of-the-board-meeting-10/ 2025-11-03T10:57:22+00:00 https://www.wockhardt.com/investor/financial-results-fy26-q2/ 2025-11-03T11:01:44+00:00 https://www.wockhardt.com/investor/wallis-laboratory-2/ 2025-11-14T05:27:41+00:00 https://www.wockhardt.com/investor/wallis-group-3/ 2025-11-14T05:28:04+00:00 https://www.wockhardt.com/investor/wallis-licensing-4/ 2025-11-14T05:28:14+00:00 https://www.wockhardt.com/investor/pinewood-healthcare-limited-9/ 2025-11-14T05:33:07+00:00 https://www.wockhardt.com/investor/wockhardt-uk-holdings-limited-10/ 2025-11-14T05:39:15+00:00 https://www.wockhardt.com/investor/newspaper-extracts-regarding-postal-ballot-notice/ 2025-11-15T13:51:16+00:00 https://www.wockhardt.com/investor/chairmans-letter-to-shareowners-q2-fy-25-26/ 2025-11-19T11:59:28+00:00 https://www.wockhardt.com/investor/newspaper-extract-notice-to-shareholders-regarding-special-window-for-re-lodgement-of-transfer-of-physical-shares-nov-2025/ 2025-11-28T10:47:05+00:00 https://www.wockhardt.com/investor/us-fda-accepts-wockhardts-new-drug-application-for-breakthrough-antibiotic-zaynich/ 2025-12-01T07:40:14+00:00 https://www.wockhardt.com/investor/us-fda-accepts-wockhardts-new-drug-application-for-breakthrough-antibiotic-zaynich-2/ 2025-12-01T07:42:03+00:00 https://www.wockhardt.com/investor/voting-results-and-scrutinizers-report-postal-ballot/ 2025-12-16T09:49:03+00:00 https://www.wockhardt.com/investor/incorporation-of-three-step-down-subsidiaries/ 2025-12-16T16:02:45+00:00

DISCLAIMER

Confirmation of your acceptance of the terms and conditions

DISCLAIMER

Confirmation of your acceptance of the terms and conditions

WEBSITE DISCLAIMER

Confirmation of your acceptance of the terms and conditions

WEBSITE DISCLAIMER

Confirmation of your acceptance of the terms and conditions